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Abstract 
Background: Traumatic brain injury (TBI) is pathology of growing international importance. Near 
Infrared spectroscopy (NIRS) represents a non-invasive, cost effective and easily applied cerebral tissue 
monitoring modality with the potential to direct therapy and guide management decisions. Currently the 
use of this technology within mainstream TBI care is limited considering its potential inherent 
advantages. A number of possible reasons may account for this under-utility, including concerns 
regarding accuracy of recovered parameters and the influence of extra-cranial superficial tissue 
physiology.  Recent advances in NIRS parameter recovery techniques and data processing potentially 
offer an improvement on previously evaluated technology.  Frequency domain (FD) parameter recovery 
NIRS is one such advancement now available in clinically viable and commercially available devices. 
This technology has not yet been evaluated within the context of TBI care. 
Aims: i) To assess the current evidence within the published literature regarding the use of NIRS within 
the field of TBI management. ii) To attempt to quantify the potential effect of extra-cranial tissue 
physiology on clinically viable NIRS devices benefiting from the latest parameter recovery techniques in 
detecting changes in cerebral tissue oxygenation. iii) To compare the abilities of a frequency domain 
clinically viable point of care NIRS device to radiological and invasive gold standards in measuring 
changes in cerebral physiology.   
Methods: A number of specific original investigations to assess the abilities of clinically viable NIRS 
technology benefiting from FD parameter recovery for use in the management of TBI patients were 
undertaken along with a review of the existing literature. Devices were evaluated against established 
invasive gold standard monitors (brain tissue oxygen tension measurement) in patients to assess its 
abilities in replacing this technology. Comparisons were also made with advanced functional MR imaging 
(fMRI) in appropriate physiological models (Valsalva manoeuvre and staged hyperventilation). An 
evaluation of the potential benefits of a device utilising FD parameter recovery against the more 
commonly used continuous wave device in controlled hypoxia in healthy individuals was undertaken, 
along with an investigation into the effect of manipulating superficial extra-cranial tissue blood flow.     
Results. NIRS has demonstrated certain useful abilities in the monitoring of cerebral oxygenation in the 
care of individuals who have sustained a TBI, however sufficient evidence does not exist to support its 
independent use in TBI. The FD NIRS device tested demonstrated good correlation with fMRI (Valsalva 
and Hyperventilation), and equivalent abilities in differentiating activity within superficial extra-cranial 
and cerebral tissue. Manipulating of blood flow into the overlying extra-cranial tissue did not significantly 
affect the output parameters seen in these models. However the FD NIRS device tested did not 
demonstrate sufficient abilities to replace invasive brain tissue oxygen tension measurement in TBI 
patients. Also, within the context of controlled hypoxia (relevant to TBI) no discernable advantage was 
observed in utilising a device benefiting from frequency domain parameter recovery. 
Conclusion:   NIRS still remains the best available prospect for a non-invasive monitoring modality to 
direct therapy and guide management in TBI care. However, further development and translation of the 
multitude of advancements in NIRS technology achieved recently in the science of biological optics may 
be required to realise this potential.  
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CHAPTER 1:  THE CLASSIFICATION OF TRAUMATIC 
BRAIN INJURY AND OVERVIEW OF 
CONTEMPORARY MONITORING TECHNIQUES, AND 
THE POTENTIAL REQUIREMENTS FOR NON-
INVASIVE DEVICES IN THIS CONTEXT  
1.1 Traumatic Brain Injury: A major problem in world health 
Traumatic brain injury (TBI) occurs when energy originating from external mechanical 
force is absorbed by the brain leading to either temporary or permanent dysfunction of 
the tissue, it is a leading cause of morbidity and mortality internationally. For a variety 
of reasons it is almost impossible to fully appreciate and account for the overall 
international burden that this disease poses, although recently published data suggests 
that approximately 13 million individuals throughout the European Union and North 
America are living with the deleterious effects of TBI
1, 2
.  
Approximately every 90 seconds an individual in the UK sustains a TBI, with between 
10 and 20,000 people sustaining a serious head injury requiring hospital admission and 
intensive therapy
1
. The effects of TBI on an individual are not limited to any single 
aspect of their life; it frequently impacts an individual’s physical/locomotive abilities, 
their cognitive function, their ability to work and be economically productive, and their 
ability to sustain meaningful relationships with their close family and friends. A 
particularly complex aspect of TBI are the cases of mild to moderate TBI (mTBI) which 
2 
make up the vast majority of injuries
3
, here sufferers outwardly appear normal, and 
casual interaction with these people frequently leaves the observer unaware of the 
underlying difficulties they experience. It has been suggested that up to 15% of these 
individuals suffer persistent symptoms and remain economically inactive years after 
their injury
4, 5
.   TBI is therefore an important and complex problem, with multiple 
factors contributing to the outcome after injury, many of which are not yet clearly 
defined or understood. Due to the sheer numbers of patients sustaining these injuries, 
any improvement (even modest) in the provision of care for patients sustaining TBI has 
the potential to translate into significant social and economic benefits for society.    
1.2 The classification of Traumatic Brain Injury 
For the purposes of both assessment and management, the severity of TBI (which is 
largely intended to be a method of quantifying the amount of damage that neurological 
structures have sustained) it is mainstream practice to classify the severity of a sustained 
injury. Traditionally this is divided into four stratifications Mild, moderate, severe, and 
(to a lesser extent) critical. Certain key parameters are used to distinguish between 
these; of particular importance is the level of consciousness/ neurological function after 
initial resuscitation measures have been undertaken.  
The established (an internationally accepted) scale for these purposes is the Glasgow 
Coma Scale (GCS)
6
, which comprises of three components; eye opening, verbal 
response, and motor response, these are scored out of 4, 5 and 6 respectively, with a 
minimum of 1 for each section. These scores are then added to form a total of between 3 
and 15. This linear scale where (a score of) 3 classifies a completely unresponsive state 
3 
and 15 represents a normal orientated and responsive person is the established standard 
of post TBI functional assessment. Other assessment measures such as the presence of 
cranial fractures, cerebro-spinal fluid (CSF) leakage and the presence or absence of intra 
cranial haematomas are significant factors when considering overall assessment, 
although not always themselves instrumental in determining the severity of injury
7
.  
1.2.1  Imaging in Classification  
Multiple scales of injury severity based on radiological data exist (particular computer 
aided tomographical imaging), of note are the Marshall and Rotterdam grading systems 
of cranial computer aided tomographical (CT) scans
8, 9
. These classify the severity of 
TBI based on the presence or absence of intra cranial haematomas (and their volume), 
the mass effect due to brain swelling, and the anatomy of the CSF cisterns. There have 
been positive reports as to the usefulness of these grading systems, and its ability to 
predict outcome
10
, and their use is certainly important in the decision making process as 
to the requirement (and specifics) of surgical intervention. However, initial findings on 
brain CT imaging are not definitive in terms of predicting the impact of injury and long 
term prognosis on an affected individual.  
1.2.2  The Pupillary reflex  
The nature of the pupillary response to light stimulus (specifically the absence of any 
response in one or both eyes) has been demonstrated to be one of the most significant 
factors in determining prognosis for an individual sustaining a TBI.  Multiple 
international investigations have demonstrated that for a given anatomical pattern of 
4 
injury or clinical presentation the absence of a response to light from either (or both) 
pupils has a deleterious impact on the likelihood of survival or a positive outcome
11, 12
.      
1.2.3  Post traumatic amnesia in classification   
Within the sub-acute TBI setting, the presence or absence (and duration) of 
posttraumatic amnesia is utilised within a number of injury severity scales
13
.  Generally 
speaking when utilising this parameter to make prognostic predictions, the longer the 
duration of inability (of an affected individual) to lay down new memory, the more 
severe the injury (with a corresponding reduction in the likelihood of a good outcome)
 
14
. This information serves as a key adjunct to the previously described clinical 
assessment methods, and has particular strength in stratifying the likely outcome in 
individuals with a milder spectrum of injuries (particularly those with a high GCS 
and/or no obvious abnormality due to trauma on imaging). However, a key time in the 
patient journey for the formulation of prognostic forecasts is in the early period after 
admission, and frequently (at this point in the clinical journey) patients are significantly 
impaired and unable to be properly assesses in this way.  
1.3 Current mainstream invasive and imaging monitoring modalities 
The most fundamental tool used to monitor a patient’s neurological status within the 
context of TBI is clinical examination.  However, when managing individuals with 
moderate and (in particular) severe TBI a pharmacologically induced state of reduced 
consciousness is often mandated. There are a variety of reasons why this is beneficial 
including a direct neuro-protective effect
15, although it removes the clinician’s ability to 
monitor the functional status of the brain by performing a comprehensive neurological 
5 
examination. Surgically important changes to the intra-cranial environment must 
therefore be monitored by other means, which to not directly measure brain function. 
1.3.1 Intra-Cranial Pressure (ICP) monitoring 
At the time of writing this measurement is the primary parameter by which therapy for 
severe TBI is guided. Pressure is monitored in real-time by an invasive probe (or 
catheter) placed into the brain parenchyma, ventricle or sub-dural space. It has been 
demonstrated that refractory intra cranial hypertension is associated with poorer 
outcomes and increased mortality; with individuals with higher ICP readings having a 
poorer prognosis then those with lower values
16,
 
17
. Data yielded from ICP monitoring 
allows the establishment and stabilisation of a satisfactory cerebral perfusion pressure, a 
number of investigations have studied the effectiveness of surgical measures to reduce 
ICP (when equipoise is present) and the evidence thus far is difficult to interperate, 
however a significant survival advantage is suggested
18, 19
.     
1.3.2 Serial Axial Imaging 
The acquisition of serial CT images within the context of TBI has been an established 
method of monitoring individuals who are at risk of developing surgically reversible 
intra cranial pathology (oedema, haematomas, and hydrocephalus) for some 
considerable time 
20
. Scans can be performed at regular intervals to monitor the 
evolution of pathological features. Evidence exists that targeted therapy using this 
monitoring modality is as effective as the monitoring of ICP in terms of outcome and 
mortality
21
, however in certain clinical situations regular return visits to a CT scanner 
6 
are impractical and may constitute an unacceptable clinical risk, especially if there are 
coexisting airway/ventilator issues.    
1.3.3 Cerebral Microdialysis 
This modality represents a significant step forward in the field of invasive brain tissue 
monitoring
22
. The technique involves the placement of a small dual lumen catheter with 
a semi permeable hollow fibre tip into the brain parenchymal tissue. Very small 
amounts of isotonic crystalloid perfusion fluid (similar to the surrounding tissue in ionic 
composition – however colloid can be used also) are then pumped through this catheter 
at a rate of between 0.1 and 5µl per minute. During its transit through the semi 
permeable catheter tip, a passive osmotically driven exchange process occurs across the 
membrane tip between the perfusion fluid and the cerebral extra cellular environment. A 
continuous (pump driven) flow of fluid through the interface means that often a 
complete equilibrium of viable (small enough to pass through the membrane pores) 
compounds is often not achieved, and this is influenced considerably by the specific 
fluid transit time
23
. As a bedside monitor and tool to monitor injury evolution together 
with treatment efficacy cerebral micro-dialysis provides invaluable information on a 
variety of metabolic parameters. In particular, information regarding oxidative 
metabolic functional status, cellular damage, substrate supply, and neurotransmitter 
concentration are commonly derived by this technique. These have demonstrated 
considerable ability in terms of prognostic prediction within the context of TBI
24
, 
however definitive evidence regarding what effect manipulating these parameters 
specifically has on patient outcome is yet to be determined
25
.     
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The versatility of cerebral microdialysis is one of its key attributes. Currently within the 
field of TBI research there is a significant amount of work underway to develop 
pharmacological therapies to improve patient outcomes. In these circumstances an 
understanding of specific mechanistic action of the tested agent is critical
26, 27
. 
Microdialysis offers a convenient and clinically viable method of making direct 
measurements from the target organ tissue, although only in cases where intra-cranial 
access is mandated.  As a research tool for developing the understanding of in vivo 
biochemical and cellular aspects of TBI injury evolution, along with the testing and 
generation of hypothesis microdialysis is arguably indispensable.  
1.3.4 Cerebral Tissue Oxygen Tension (PbtO2) 
Brain tissue oxygen tension measurement concerns quantifying the total amount of 
oxygen available to the cells within the portion of the central nervous system being 
observed (tissue adjacent to the probe). In a similar manor to the previously described 
intra-cranial monitoring techniques this measurement involves the placement of a thin 
catheter into the brain parenchyma.  
In general commercially available and clinically certified devices measure the freely 
available tissue oxygen by one of 2 methods.  
1) The Clarke cell; This principle was first established in the late 19
th
 century, and uses 
a catalytic electrode (frequently platinum) to reduce the free (O2 form)oxygen within the 
tissue thereby establishing an effective electrical potential difference. With subsequent 
calibration this has been demonstrated to provide an accurate measurement of free 
8 
oxygen within biological tissues
28
, frequently a gas permeable shield is used to protect 
the electrode surface and preserve measurement in vivo.      
2) Quenching florescence; fundamentally this technique relies in the action of oxygfen 
in reducing (quenching) the florescence of formaldehyde dissolved pyrene di-butyric 
acid within a semi permeable membrane
29
. It has been established that this technique is 
at least as good as electrode-based methods in detecting levels (and changes) of oxygen 
within a biological environment
30
.  A proposed advantage of this method of tissue 
oxygen measurement is a resistance to the inherent drift of output parameters 
encountered in direct electrode based measurements, along with a possible reduced 
likelihood of contamination by cellular debris. The utility of fibre optic carriage can 
enhances this method by allowing a lightweight and thinner probes to be inserted into 
the brain with analysis taking place remotely.   
Brain tissue oxygen was introduced as an adjunct to monitoring in severe TBI in 
acknowledgment to the perceived limitations of ICP monitoring alone
31
, and from its 
inception it was clear that measurements were dependant on multiple physiological 
factors. A small number of investigations in which the outcomes of patients treated with 
PbtO2 guided therapy were compared with historical outcome data from patients with 
management guided by ICP demonstrated an improved outcome with PbtO2 guided 
managment
32, 33
. In particular, these investigations highlighted significant potential 
improvements when PbtO2 guidance was applied to closed head injuries in the absence 
of mass lesions (haematoma). Despite this, no level 1 evidence that PbtO2 directed 
therapy positively influences outcome currently exists, although investigations to this 
effect are underway.  
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The manipulation of PbtO2 is possible by controlling a variety of parameters
34, 35
, 
including cerebral perfusion pressure (CPP), ventilator rate, and inspired oxygen 
fraction (F). A criticism of this technique is that the discreetly placed catheter provides 
information about the available oxygen in the small area of brain adjacent to the 
catheter
36
, rather than a reflection of global activity as provided by certain other 
modalities (Jugular Venous Oxygen Saturation).  
1.3.5 Jugular Venous Oxygen Saturation (SvjO2) 
The monitoring of jugular venous oxygen saturation is an established invasive 
monitoring modality within the context of TBI
37
. The paired internal jugular veins (and 
bulbs) together exclusively drain venous blood from the brain and neurological tissues. 
As the brain is exclusively reliant on oxygen and metabolic substrates carried by the 
circulating blood for metabolic activity a contemporaneous comparison of arterial and 
jugular venous blood saturation will give an indication of cerebral oxygen requirement. 
SvjO2 represents a global measure, and has been demonstrated in studies comparing it 
with PbtO2 that within the context of focal pathology localised ischemic events may be 
missed
38
. 
Measurement of SvjO2 is established by inserting a thin transducer catheter into the 
internal jugular vein via the neck, this catheter is then passed up stream (towards the 
brain) into the region of the jugular bulb (occasionally under image guidance). Both low 
and high SvjO2 levels have been associated with a poorer patient outcome
39, 40
, where 
high levels of venous saturation indicate an impaired ability of the brain tissue to extract 
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oxygen from tissue or direct shunting of blood from the arterial to the venous 
compartments (possibly during periods of raised intra-cranial pressure).  
No strong evidence exists supporting that the manipulation of SvjO2 within the context 
of TBI has any positive impact on outcome. Other factors limiting this method of 
monitoring cerebral oxygenation is the concerns regarding extra cranial 
contamination
+41,+42
 (strongly dependant of the proximity of the catheter to the jugular 
bulb). These factors, along with the advent of PbtO2 monitoring within specialist 
centres have made SvjO2 measurement in TBI less widespread.  
1.4 Potential benefits of a non-invasive monitoring modalities  
A clear disadvantage of all the previously discussed monitoring modalities is their 
highly invasive nature. As discussed, their placement involves either the creation of an 
access hole into the cranium, with subsequent passage into the brain parenchyma, or 
insertion into a major blood vessel.  Overt complications of this type of monitoring 
include intra-cranial bleeding and haematomas, misplacement of the device (often into 
deeper structures) leakage of CSF, potential direct injury to the brain and infection. Less 
obvious problems considered include imaging artefact (particularly magnetic resonance 
imaging (MRI)) and more complex patient transport/transfer. Occasionally scaring and 
the unfortunate permanent defect within the cranium can be cosmetically troubling to 
certain patients, and this should also be considered in balancing the risks of invasive 
monitoring within the context of TBI.   
Another important consideration (particularly within a finite resource healthcare 
provision setting) is cost.  There are a variety of associated costs, most notably the 
11 
requirement of expensive single use invasive catheters in all cases. In addition to this, 
each invasive device requires specific equipment to translate the recovered parameters 
into a clinically usable output. All invasive neurological monitoring is carried out within 
the confines of costly specialist critical care units, and the expense of transferring TBI 
patients to these units must also be considered.       
Any non-invasive monitoring modality capable of replacing any of the aforementioned 
invasive measures could possibly negate these risks and costs. However, what is 
possibly more important is the potential for moving the brain tissue directed 
management further forward in the patient journey. As discussed, currently the first 
occasion (in the course of treating TBI) where any manipulation of physiological 
parameters aimed at specifically improving cerebral tissue perfusion, or influencing 
neurological outcome can be undertaken is after the insertion of an invasive monitoring 
device. Obtaining appropriate imaging (CT) also represents a significant point in the 
patient journey where management decisions are taken to optimise neurological 
outcome. Here critical decisions regarding surgical interventions are made, however in 
many cases imaging does not allow you determine the functional potential and 
physiological status of the patient in question. Also, imaging is frequently undertaken 
some hours after the initial traumatic insult, following admission to an appropriate 
secondary care environment. These factors effectively translate to a potentially 
significant window of time after TBI in which no resuscitative measures can be 
specifically targeted at optimising the environment for the brain.    
Beyond clinical examination (GCS) and obvious basic vital sign monitoring (blood 
pressure, temperature, pupil response, urinalysis), there are no truly viable monitoring 
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or assessment modalities available to the clinician (with proven reliability) during this 
critical period of medical management to direct therapy specifically toward the 
preservation of brain tissue.  A device capable of observing an accurate non-invasive 
parameter of brain health would prove invaluable in such circumstances.  
Such a tool would need to satisfy certain key criteria to be considered clinically viable 
within the clinical context of pre-hospital (early) TBI care; 
1. The monitor would need to be quickly and easily applied, preferably at a readily 
accessible anatomical location, or potentially require no body surface interface at 
all. Application and setup of the device and associated equipment should not 
interfere with the provision of standard clinical care. 
2. Any proposed monitor interface (with the surface of the body) would require a level 
of preparation that could be undertaken in a range of environments. 
3. The device would be sufficiently resistant to ambient factors such as variations in 
light intensity, both acoustic and electrical noise and movement artefact.  
4. The inter-user variability of the monitor should be minimal, in that a change in 
parameters indicating a clinically significant shift in physiology would be clearly 
differentiable from the changes in parameters observed when the device is applied 
by different individuals (with subtly different techniques), or at a marginally 
different anatomical location.  
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5. The clinical information provided by the device should be useful, and contribute to 
the management of the TBI. 
6. The device should have the basic ability to differentiate between overtly 
pathological brain physiology and that of normal function. Although a small degree 
of inconsistency is both inevitable and acceptable, the variability of readings 
between individuals should not exceed the change seen during a clinically 
significant change in activity (ischemic/hypoxic event).  
7. Although the cost and value for money will depend on the value added by the 
monitoring modality, the cost of the device should not be prohibitive (particularly in 
a finite resource healthcare system).  
1.5 Currently available non-invasive monitoring modalities 
1.5.1 Trans Cranial Doppler 
Trans Cranial Doppler (TCD) also known as acoustocerebrography, is a non-invasive 
monitoring modality utilising ultrasound (and the associated Doppler effect) to elicit the 
velocity of blood flow within key basal arteries supplying the brain (particularly the 
middle cerebral artery). Essentially the probe applied to the external surface of the head 
consists of an ultrasound source (usually 2Mhz) and detector, with a corresponding 
focusing apparatus with an optimal depth target (usually via a polystyrene lens, with a 
focus distance of 50mm). In adult practice, the probe is placed over the temporal area of 
the patients head (the probe sitting over the temporalis muscle/tendon slightly superior 
to the zygomatic arch) which in turn overlies a thin portion of the skull (pterional 
14 
region) providing a suitable sonographic ‘window’ parallel to the lie of the middle 
cerebral artery (a significant feeding artery and branch of the intra-cranial carotid 
artery). The exact position is adjusted by monitoring the device feedback until a 
satisfactory arterial signal is isolated. Without the specific dimensions of the observed 
vessels, accurate assessment of the volume of blood passed through the observed artery 
is not possible with TCD. Therefore this modality’s primary utility is in observing 
relative changes in the velocity of flow within the target artery
43
. TCD has demonstrated 
significant utility in the fields of spontaneous sub-arachnoid haemorrhage
44, 45
 and 
ischemic stroke
46, 47
.  
Numerous studies have investigated the application of this modality to the direction of 
therapy and the predicting of outcome in TBI, with promising early results
48, 49
. More 
recent investigations have confirmed the potential utility of TCD in this context
50, 51
, 
however their results suggest that the modality lacks the specificity to be utilised as an 
independent monitoring tool. No definitive evidence exists to confirm that TCD can be 
utilised usefully in the pre-hospital TBI setting, however an interesting investigation by 
Tazarourte et al
52
 provides a proof of concept that this feasible. Although this small 
study demonstrated the potential that TCD has to predict mortality, other key clinical 
signs (unreactive pupils) were present in the majority of these patients who failed to 
survive. Therefore in most cases the use of TCD did not necessarily add useful 
information that would have changed the course of management. This uncertainty 
together with concerns over inter-user variability
53
 without specific training 
requirements, costs and equipment practicalities have perhaps contributed to TCD not 
being commonly incorporated into TBI monitoring protocols. Despite this, TCD 
certainly has potential as an important component of future research into non-invasive 
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monitoring in TBI, but currently fails to meet our specified criteria for a viable non-
invasive monitor.     
1.5.2 Electro-Encephalogram  
The electro-encephalogram (EEG) is a long established non-invasive method of 
monitoring cortical electrical activity; this is achieved primarily by the placement of a 
network of scalp contact electrodes, establishing patterns and detecting changes in 
neuronal activity. The EEG has proven useful in a multitude of clinical specialities, 
particularly in fields of neurology and neurosurgery involving the monitoring and 
treatment of seizures. Within the context of TBI, EEG has played an important role in 
clearly defining the incidence and impact of sub clinical seizure activity
54
, demonstrated 
utility in stratification of injury severity
55
, and (in conjunction with somato-sensory 
potential measurement) demonstrated potential in predicting important prognostic 
information
56
. EEG parameters are also useful in the titration and dose optimisation of 
certain drugs used in the intensive management of severe TBI
57
.   
Spreading cortical depressions are waves of abnormal cortical neurophysiological (and 
vascular) activity
58
, from a discreet origin they spread progressively across the cortical 
surface at a measurable velocity
59
. These have been identified as important events in the 
evolutional physiology of TBI
60
. EEG in both its non-invasive and invasive forms (sub-
dural strip electrodes or parenchymal depth electrodes) have been instrumental in 
establishing the current knowledge base around this phenomena, and the ongoing 
further work into how these principles can be integrated into mainstream TBI care.   
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Within current mainstream moderate to severe TBI care the EEG is (as described) in 
non-invasive form an important diagnostic tool where required, and potentially useful 
adjuvant for predicting outcome and forecasting prognosis. Despite this it does not 
constitute a core component of many mainstream care protocols, and has been 
considered underutilised in these circumstances
61
. A number of factors may plausibly 
account for this, including the practicality of applying an effective array in an acute 
clinical setting, the difficulty in interpreting results without specialist input together 
with a lack of evidence supporting specific intervention based on output parameters. 
EEG therefore represents a potential growth area and exciting avenue of further 
investigation within this context, from assessment to rehabilitation
62, 63
, and in the 
milder injury spectrum
64
. However, on balance this modality does not currently meet all 
of our specified viability criteria as an independent non-invasive monitor. 
1.5.3 Pupilometry  
Incorporating information regarding the reactivity of the pupil has been fundamental to 
neurosurgical practice since its inception, the presence or absence of the pupillary light 
reflex is established as a critically important prognostic information
65
. The concept of 
pupilometry extends beyond the basic digital parameter of a ‘reactive’ or ‘unreactive’ 
pupillary response, and quantifies the dynamic parameters of the reflex (e.g. latency, 
constriction velocity, % change). A number of commercially available, clinically viable, 
hand held devices have been utilised in the treatment of TBI critical care
66
.   
A number of investigations have suggested that subtle changes in pupil reactivity may 
be predictive of developing intra-cranial pathology
67
, and these observations have 
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contributed to promising proposed roles for pupilometry within multimodal TBI 
monitoring.  However there are a number of significant limitations in these studies, and 
significant equipment costs may have contributed to slow clinical uptake of this 
technology.  Overall the current evidence surrounding the use of pupilometry to direct 
clinical decision-making in TBI is not sufficiently robust to support its utility, 
significant further work is required in order to meet our proposed criteria as an 
independently usable within this field.  
1.5.4 Non-invasive ICP measurement 
Within the literature there are a number of successful examples of recording ICP 
independent of any invasive transduction device utilising a number of methods 
including optic nerve sheath blood flow
68, 69
 and diameter, or tympanic membrane 
displacement
70
. Although appealing in terms of easy utility and avoiding the potential 
morbidity associated with invasive monitors, thus far these devices have not yet proved 
sufficiently accurate to replace their invasive equivalents
71
. These factors once again 
indicate this modality lacks the required level technological maturity or level of 
evidence to meet our proposed criteria for an independently usable monitor. 
1.5.5 Near Infra-Red Spectroscopy 
The concept of using Near Infra-Red Spectroscopy (NIRS) to observe the changes in 
concentration of key molecules (chromophores) within the brain tissue was originally 
developed in the 1980s
72
, however mainstream uptake of the device into TBI care has 
been modest
73
. A light source and detector (incorporated into a skin applicable probe) 
are applied to the skin/scalp surface over brain tissue, from here light with a wavelength 
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between 600 and 1000nm is emitted. The light then follows a loosely parabolic 
trajectory through the tissue from the point of source to the light detector. The further 
away from the point of source, the deeper the path the photon will take. The maximum 
practical depth resolvable in this context is approximately 2cm
74
, which allows the 
derivation of parameters from the cerebral cortex.  
A number of clinically viable devices are commercially available, all of which a 
relatively easy to use in a variety of clinical situations, including out of hospital care
75
. 
Generally these devices have been tested with the detection probes placed on the 
forehead, as this represents an easily accessible portion of (usually) hairless skin 
reliably overlying brain tissue. An adequate probe/skin interface together with the 
absence of contaminants is essential to ensure optimal output parameters.  
Due to certain algorithmic assumptions, and the basic physical constraints of devices 
used in clinical TBI practice NIRS is principally only usable to detect relative changes 
from a subject specific baseline
76
.  This places certain limitations on the abilities of this 
modality as an independent monitor, particularly at the first point of care. More 
advanced parameter recovery techniques and data processing are contributing to 
improvements to rectify these
77, 78
. Established research has demonstrated that for 
detecting the presence of traumatic mass lesions NIRS can be an effective screening 
tool
79
.  
Despite the relatively modest penetration of this technology into the TBI arena, and the 
relatively low level of evidence supporting its independent use for this purpose (not 
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adequate to meet our specification) NIRS has a number of attractive attributes and has 
clear potential.   
1.6 Summary   
TBI represents a complex, heterogeneous and multi-factorial pathology which despite 
multiple large-scale investigations is yet to be comprehensively understood. Fit for 
purpose neurological monitoring is and will continue to be instrumental in evolving our 
understanding. Although not an intervention in itself, multi modal monitoring of the 
brains physiology together with its various essential supportive organs is critical in 
targeting any meaningful treatment. Any future therapies designed to improve the care 
and outcome of TBI patients of all grades of severity would need monitoring modalities 
of sufficient resolution to determine the point at which intervention is necessary 
together with providing time appropriate feedback as to their effect. 
Invasive clinical monitoring techniques are currently the cornerstone of TBI 
neurological critical care. They have achieved a great deal in increasing our 
understanding of a variety of aspects of this extremely complex condition, including the 
pathophysiology of secondary injury in the hours and days after impact. Each of these 
modalities is imperfect, and may be misleading in isolation. Therefore a multi-factorial 
overview of all monitored parameters is essential
21
.  A critical inflexibility of this type 
of monitoring is (by definition) its invasive nature, which limits both when and where it 
can be applied. Any validated non-invasive equivalent has the potential to move the 
commencement of monitoring further forward in the patient journey (as discussed), 
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together with enabling brain specific monitoring and direction of therapy to be 
undertaken in a greater variety of clinical settings.  
Unfortunately no non-invasive monitoring modality currently available has 
demonstrated sufficient levels of reliability, interpretability and viability (in the clinical 
environment) to be utilised as a standalone method of monitoring in TBI. Ongoing 
research in both the clinical and pre-clinical setting will hopefully serve to address these 
current shortfalls.  
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CHAPTER 2:  OVERVIEW OF THESIS AIMS AND 
HYPOTHESIS 
Unifying hypothesis 
The unifying hypothesis throughout this thesis is that point of care, clinically viable 
near infrared spectroscopy technology benefiting from frequency domain parameter 
recovery is capable of observing clinically relevant changes in cerebral physiology 
independent of superficial (extra cranial) tissue perfusion, and has clinically translatable 
benefits to previously utilised continuous wave devices.  In addition to this we believe 
that this non-invasive monitoring modlitiy has equivalent abilities to imaging and 
invasive gold standards (functional magnetic resonance imaging and invasively 
measured cerebral tissue oxygen tension). Through these capabilities we believe that 
these devices can be used as independent means of monitoring cerebral physiology 
within the context of traumatic brain injury.  
Overview 
As highlighted in this introduction, a clinically viable non-invasive neurological 
monitor that demonstrates equivalence to invasive or impractical (imaging) modalities 
currently utilised in traumatic brain injury (TBI) care would have clear advantages that 
are immediately translatable to the field. 
Within the field of Near Infra-Red spectroscopy (NIRS) and its related optical 
monitoring techniques (diffuse optical tomography) there are numerous methods and 
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techniques utilised for parameter recovery. These vary from custom-built laboratory 
based arrays to commercially available and from simple source/detector configuration 
probes designed to be placed over a small area of forehead (or bare scalp) to large whole 
head source-detector arrays. Currently translatable technology that could be applicable 
to range of clinical environments excludes some of these tools utilised in optical 
research.  
Complex arrays represent an unfeasible option for TBI care currently due to practicality, 
time and cost factors. Certain data reconstruction techniques require post-hoc 
processing and are unable to currently provide clinically practical real-time output
1
. 
However, many advanced NIRS parameter recovery techniques (frequency domain
2
 / 
time domain
3
) are utilised by commercially available (and safety approved) point-of-
care devices with simple to apply probes usable in this environment (with basic skin 
preparation).  
The vast majority of published works within the literature investigating the abilities of 
NIRS within the field of TBI have used devices that employ continuous wave parameter 
recovery technology
4-6
, and have concluded it not sufficiently accurate to be utilised as 
an independent monitoring modality and not suitable to replace any currently utilised 
invasive device. Potentially systems that benefit advanced parameter recovery 
techniques could improve this set of circumstances. There is also a degree of uncertainty 
as to the specific abilities and limitations of this technology within the field
4
, with a 
variety of concerns including the role of physiological changes in superficial extra-
cranial tissue
7
 in influencing the output parameters from clinically applied devices with 
real-time outputs.  
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The aims of my investigation are therefore; 
1. To assess the current body of evidence relating to the abilities of NIRS (in all forms) 
to be utilised as an independent monitoring modality in the context of TBI.   
2. To ascertain if a clinically viable NIRS device utilising frequency domain 
technology offers any clear translatable advantages to TBI care over previously 
utilised technology in detecting clinically important changes in cerebral physiology.  
3. To ascertain if the effect of confounding superficial (extra cranial) vascular activity 
prevents the effective identification of significant physiological changes pertinent to 
TBI care by NIRS devices utilising frequency domain parameter recovery.  
4. To compare the abilities of a clinically viable NIRS device utilising an advanced 
recovery technique (frequency domain) to established gold standard measured of 
cerebral physiology (functional magnetic resonance imaging). 
5. To investigate if a clinically viable NIRS device utilising frequency domain 
technology has the ability to detect changes in invasively measured brain tissue 
oxygen tension in patients who have sustained severe traumatic brain injury. From 
this I would like to ascertain if this enhanced non-invasive technology is currently 
able to replace this current invasive gold standard.  
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CHAPTER 3:  NEAR-INFRARED SPECTROSCOPY IN 
THE MONITORING OF ADULT TRAUMATIC BRAIN 
INJURY: A REVIEW 
Abstract 
Background: Cerebral near infra-red spectroscopy (NIRS) has long represented an 
exciting prospect for the non-invasive monitoring of cerebral tissue oxygenation and 
perfusion in the context of traumatic brain injury (TBI), although uncertainty still exists 
regarding the reliability of this technology specifically within this field. Methods: We 
have undertaken a review of the existing literature relating to the application of NIRS 
within TBI. Results: We discuss current ‘state-of-the-art’ NIRS monitoring, provide a 
brief background of the technology, and discuss the evidence regarding the ability of 
NIRS to substitute established invasive monitoring in TBI. Conclusion: Currently, 
sufficient evidence does not exist to support the use of NIRS as an independent 
monitoring modality in cases of adult TBI.     
3.1 Background 
Approximately every 90 seconds an individual in the UK sustains a traumatic brain 
injury (TBI), with 10 - 20,000 people every year sustaining a serious head injury 
requiring hospital admission and intensive therapy.
1
 A key facet in the management of 
the injured brain is close monitoring to guide intervention. 
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Cerebral near infra-red spectroscopy (NIRS) has long represented an exciting prospect 
for the non-invasive monitoring of cerebral tissue oxygenation and perfusion in the 
context of brain injury, and as a ‘work-in-progress’ has demonstrated great potential.2 
Recent developments in both the NIRS technology and techniques used to derive 
cerebral NIRS measures are leading to more accurate and usable data to guide therapy, 
and thus NIRS is potentially closer to becoming a mainstream method of cerebral 
monitoring.    
Cerebral NIRS (Fig. 1), as a non-invasive and easily applied method, has exciting 
potential to allow significantly earlier commencement of cerebral tissue monitoring 
with minimal inter-operator variability in output. Conceivably, this could be applied at 
the earliest phase of head injury resuscitation (e.g., from the point of first pre-hospital 
contact), as opposed to current invasive monitoring, which needs admission to a 
specialised intensive therapy unit. The purpose of this review is to describe the 
technology and to evaluate the current evidence surrounding its use in the context of 
adult traumatic brain injury and to consider the current limitations and criticisms 
surrounding NIRS in these circumstances. 
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Figure 3.1. NIRS concept illistrated 
3.2 Introduction to the Technology 
Sir William Herschel (1738-1822) first described infra-red radiation in 1800 whilst 
observing sunlight through a red coloured filter; he passed the resultant filtrate through 
a prism and observed the surprising heat adjacent to the limits of the visible red light. 
This led to the deduction that non-visible portions of the light/electromagnetic spectrum 
were responsible for the localised rise in temperature, and the concept of infra-red light 
was established.  
Near infra-red (NIR) is a term used to define light with wavelengths varying from 
approximately 600 nm to 1000 nm, with ‘true’ infra-red light having wavelengths of up 
to 1 mm. This wavelength range describes a window within which biological tissues are 
relatively translucent due to the low molar absorptivity of the tissue’s key 
‘chromophore’ constituents (Fig 2). One of the fundamental principles of NIRS is that 
the absorption characteristics of each chromophore are unique, so detector signals can 
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be ‘unmixed’ to quantify the relative amounts of each chromophore in a target tissue. 
As light wavelengths expand above 1000 nm absorption by water becomes too 
significant to allow effective transmission through tissues, and below 600 nm scattering 
and absorption lead to the same operational shortcomings.
3
  
 
Figure 3.2. Spectrum window for NIRS 
Between 600 and 1000 nm absorption is relatively low, so scattering is the dominant 
tissue interaction process for NIR light. A detailed physical explanation of this is 
beyond the scope of this review; however the scatter allows NIR light to be transmitted 
several centimetres into biological tissue, hence its potentially useful role in non-
invasive medical imaging and spectroscopy. While NIR light can be utilised for 
functional imaging, giving a spatially resolved map of chromophore concentrations, the 
majority of instruments currently in use are small scale NIR spectroscopes which 
provide a global measurement of chromophore concentrations within the target tissue. 
Oxygenated and deoxygenated haemoglobin are the most commonly targeted 
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chromophores, knowledge as to the signal strength of these substances delivers useful 
clinical information regarding blood supply and oxygen transport within the tissues of 
interest.     
Optical monitoring of living tissues in the NIR region of the spectrum (600 to 1000 nm) 
was first demonstrated in 1977 by Jobsis et al.
3
 Here observations were made in feline 
(brain) and canine (heart) models looking at chromophores such as oxygenated and 
deoxygenated haemoglobin and certain essential cytochromes (a,a3) involved in 
oxidative metabolism. In 1985 Ferrari et al.
4
 published the first description of the 
application of cerebral monitoring using NIRS, and in 1993 the first commercially 
available NIRS device was marketed by Somanetics (INVOS
®
 3100).  
Since this initial introduction to the clinical environment the use of NIRS has become 
widespread. It has been applied in obtaining an average value for oxygen saturation 
across arteriolar, capillary and venous compartments in numerous types of observed 
tissues. Similar technology that uses pulsed signals to resolve arterial/arteriolar 
components in the measurement of peripheral haemoglobin oxygen saturation
 5
 (i.e., 
pulse oximetry) is almost universally used across all acute clinical disciplines in some 
form or another.  
3.3 Physical Principles and Detection Modes 
The light that is received and processed after its transmission through the brain tissue is 
the primary means by which the concentrations of the target chromophores can be 
deduced. Due to the highly scattering nature of NIR light in tissue (Fig 1), light does not 
travel on a linear path. Therefore variability in the detected signal cannot simply be 
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attributed to changes in chromophore concentration. Consequently, some form of 
computational reconstruction is required. 
6
  
The Beer-Lambert law (Equ .1) is a form of logical modelling relating the absorption of 
light to the properties of the material through which the light is travelling. In this model 
ε is used to represent the known molar absorptivity of the target chromophore (specific 
extinction coefficient), I represents the intensity of the pre (I) and post (I0) transmission 
light and, using these, the concentration of the chromophore, c, can be derived (i.e., 
oxygenated haemoglobin).   
  𝑙𝑜𝑔10 (
𝐼0
𝐼
) = 𝜀𝑙𝑐 
Equation 3.1. Beer Lambert Law 
As we observe, this law assumes 100% transmission of light through the examined 
media and no scattering affect. To account for this, a modified Beer-Lambert law (Equ. 
2) was developed by Delpy et al
7
 in 1988 employing differential path length (L) to 
calculate multiple chromophore concentrations (C), using measured attenuation (A) at 
multiple wavelengths (λ). Extinction coefficients, ε, were provided in a matrix with a 
value for every chromophore (i) at a given wavelength (j). Despite this advance, the 
model is still limited by blanket assumptions (regarding homogeneity of the tissues) and 
a single adaption to consider path length, both of which hinder (but do not exclude) its 
usefulness in clinical devices for detecting the concentration of chromophore in tissues 
where scatter is significant. Most commercially available NIRS devices are still 
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underpinned by this principle. Recent advances in modelling which seek to improve on 
the sensitivity of the technology are discussed later in this review.   
 
  [[
∆𝐶1
∆𝐶2
]]  =
1
𝐿
[𝜀𝑖,𝑗]
−1
[
∆𝐴(𝜆1)
∆𝐴(𝜆2)
∆𝐴(𝜆3)
] 
Equation 3.2. Modified Beer Lambert Law 
While modelling is important to the accuracy of NIRS systems, it is also influenced by 
the quality of the obtained detector measurements. There are three different detection 
modes used in NIRS, continuous wave, frequency domain and time domain (Fig. 3). 
 
Figure 3.3. An illustration of NIRS parameter recovery techniques 
1. Continuous Wave (CW) - CW instruments are the most simplistic of the three types. 
They rely solely on measuring attenuation of the input light (Fig. 3A) and thus 
provide a fast and relatively inexpensive method of assessment; however they 
cannot give absolute measurements. There is also no inherent information generated 
about the spatial origins of the obtained signal; for this multiple location 
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measurements are required. The In Vivo Optical Spectroscopy (INVOS
®
) System 
produced by Somanetics is an example of a system using CW resolution technology. 
This is by far the most popular system employed in clinical practice.  
2. Frequency Domain (FD) – In FD instruments the source light is amplitude 
modulated at frequencies in the MHz range. The high-frequency modulation 
employed in FD systems allows measurement of both phase and intensity of 
generated signals (Fig 3B). This allows for a more quantitative assessment of the 
optical properties of the tissues as phase data can be used to calculate a more 
accurate path length for the medium. 
3. Time Domain (TD) - TD systems measure the time of flight of photons and give the 
best spatial resolution when it comes to locating the origin of a chromophore signal, 
however they are the most expensive instruments as picosecond NIR sources and 
gated detectors are required. The broadening of the output light yields information 
about the scattering properties of the medium and the decay in amplitude infers 
information about the light absorption characteristics of the tissue (Fig 3C). 
The vast majority of clinical investigations utilising cerebral NIRS in trauma employed 
continuous wave technology with spatial/depth resolution (particular indices discussed 
later in this review). The theoretical benefits of more complex NIRS devices 
incorporating frequency modulation are yet to be properly investigated. 
Recent developments in software modelling for light absorption and scatter through 
biological tissue have enabled far more accurate predictions of how the light emitted 
from these detectors travels through the tissues of the scalp, cranium and brain.
8
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Modelling methods, such as those employed by the NIRFAST,
9
 use atlas-based 
anatomical tissue registration and finite element models to predict absorption and scatter 
through tissues (Fig 4). These computational methods have been useful in validating the 
origins of the output data obtained from NIRS equipment, 
8
 demonstrating whether the 
parameters observed by the clinician are indeed reflective of characteristics of deeper 
relevant tissue. Model based analysis can also be advantageous in deciding which 
commercially available device is most sensitive in observing the required target tissue 
depth.  
 
Figure 3.4. Computational modelling of NIRS based on subject specific imaging 
3.4 Current Application 
Interest in the utilisation of NIRS monitoring in adult clinical practice is based on some 
inherent advantages it has over other mainstream invasive methods of cerebral 
parameter monitoring, most notably its non-invasive nature, its ease of use and the 
minimal inter-operator variability in detection. Its versatility, in terms of potential for 
use in a variety of environments, is also of great interest, including the 
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possibility/viability of NIRS use in pre-hospital care
10
 and initial patient resuscitation. 
Despite this, the implementation of NIRS techniques into mainstream clinical practice 
has lagged behind its widespread use in pre-clinical research.
2, 11
 Many reasons have 
been speculated on for this dichotomy, including the problems of potential 
contamination of the signal by activity in superficial tissues.  
Currently the most frequent use of cerebral NIRS outside of neonatology is in the 
monitoring of patients undergoing cardiac, great vessel and carotid artery surgery.
12, 13
 
In these situations, changes in the initially measured baseline cerebral tissue 
haemoglobin oxygen saturation (rSO2) are monitored, and the goal of supportive 
intervention is to maintain this value through surgery at a minimum of 75% of the 
baseline reading. Avoiding incidences of ‘desaturation’ is believed to reduce 
complications relating to cerebral ischemia during these procedures and, although the 
evidence for this is not fully conclusive, data does indicate that NIRS monitored 
patients with higher baseline rSO2 suffer a lower rate of mortality than those who are 
not monitored with this modality.
14, 15
  
The use of NIRS in the context of adult TBI is currently not widespread,
2
 although 
intuitively it is in these patients where cerebral NIRS would be most useful in terms of 
monitoring whether adequate brain tissue oxygenation and vascular haemostasis is 
maintained, not only in the neurological critical care environment but also in the 
resuscitation and post resuscitation periods. However, the contamination of signal from 
extra-cranial tissue has been of concern for some time.
16
 Further, inherent difficulties in 
the implementation of NIRS techniques in the context of brain injury exist that have 
inhibited the widespread introduction of NIRS techniques for these patients (such as 
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scalp and facial injuries and the presence of haematomas). Indeed, with current methods 
the baseline reading obtained for rSO2 is highly variable and rarely gives an accurate 
absolute value. Therefore, what is more useful in all clinical scenarios is to monitor the 
trend in terms of deviation from the baseline rSO2 levels. In the traumatically injured 
brain the variability in baseline saturation readings is even greater
2, 15, 16
 due to loss of 
normal cerebral vascular auto-regulation, and the subsequent changes from this baseline 
are more difficult to interpret. This combined with the frequent presence of sub-dural, 
epidural and extra-cranial haematomas that further confound saturation signals, have 
prevented NIRS based observation in TBI from becoming widespread and routine. The 
presence of haematomas has such a profound effect on NIRS derived rSO2 readings that 
this perturbation itself has been exploited to demonstrate the presence of intra-cranial 
haematomas.
17, 18
 In addition, individuals who sustain a significant intra-cranial injury 
frequently have significant concurrent extra-cranial injuries. The systemic stress placed 
on an individual with such complex injuries has a profound effect on the quality of 
perfusion and oxygen consumption in the extra-cranial tissues (skin, scalp) and, thus, 
the sophistication of differential algorithms employed by NIRS devices in such 
situations become all the more important. Therefore, currently within TBI where a 
patient requires cerebro-protective sedation and intensive monitoring it is not accepted 
practice to use NIRS as a single modality for brain tissue monitoring.
18-21
 
3.5 Spatially resolved NIRS derived output and their usefulness  
Traditionally, the primary output of NIRS devices gives specific information on the 
saturation of haemoglobin within the broadly observed target tissue. Recently more 
eloquent algorithmic methods, based on multiple (spatially varying) detector 
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measurements have produced specially resolved data that reflects concentrations of both 
oxygenated haemoglobin (OHb) and deoxygenated haemoglobin (HHb) specifically 
within the deeper/intra-cranial zone of observation. The following examples of spatially 
resolved parameters are not exhaustive, but serve as an illustration.  
The ‘Tissue Oxygenation Index’ (TOI) and ‘Total Haemoglobin Index’ (THI) generated 
by the NIRO Hamamatsu system (Hamamatsu Photonics KK, Hamamatsu, Japan) are 
derived NIRS parameters conceived to give a better reflection of the information 
derived from deeper target tissues. The TOI (expressed as a percentage index) is 
calculated using depth resolved total tissue haemoglobin (Hb) alongside the relative 
concentrations of OHb and HHb as identified by the relative NIRS tissue absorbance.
10, 
22
 It has been demonstrated to be a useful guide to the threshold of cerebral ischemia 
and a reflection of cerebral tissue oxygenation specifically in certain circumstances.
22
  
Lam et al
23 
demonstrated that a 13% decrease from baseline of the TOI was 100% 
sensitive and 93.2% specific in detecting clinically significant cerebral oxygen 
desaturation. This was established by the decrease in cerebral function (intra-operative 
cerebral function monitoring) during carotid artery clamping and bypass at 
endarterectomy using the Hamamatsu NIRO 300 NIRS monitor (space/distance 
resolved). Importantly, this investigation made significant progress in resolving 
component contributions from the external carotid artery (ECA) and internal carotid 
(ICA), minimising the often confounding surface effect of skin and other extra-cranial 
tissue perfusions which have been described. 
20, 22, 24
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The THI is a NIRS output parameter derived largely from a depth resolved combined 
tissue Hb signal strength
20
 and has been utilised primarily to provide a surrogate for 
total tissue Hb content within the observed tissue. Intuitively this is not entirely accurate 
as the exact total volume of tissue under observation through the absorption of the 
emitted light is not known (it is therefore expressed as an arbitrary unit), although 
educated estimates have been formulated through novel computational modelling 
processes.
25
 As an extrapolation of this work, the THI could be utilised as an indirect 
measure of blood flow and vaso-motor activity in the observed tissue. In clinical 
observations involving patients in severe cardiovascular compromise, the THI 
(alongside other NIRS based parameters) has been demonstrated to be an effective 
reflection of tissue perfusion blood volume when correlated with established invasive 
parameters.
26, 27
         
3.6 Evidence for the Use of NIRS in TBI 
As discussed earlier in this review, currently the most popular uses for cerebral NIRS in 
adult clinical practice is within the context of cardiac and vascular surgery where close 
monitoring of cerebral perfusion is required during periods of cardio-pulmonary bypass. 
These situations most frequently involve normal cerebral anatomy and auto-regulation. 
The fact that both of these are disrupted by TBI makes interpretation of the observed 
parameters in this situation that much more complicated. It is currently accepted that the 
intervention threshold for a drop in haemoglobin saturation as observed by cerebral 
NIRS is between 13-17%
13-15
 to avoid damage to brain tissue, but in the context of TBI 
the utility of this threshold is less clear. 
46 
Cerebral NIRS is a more established monitoring modality in paediatric and neonatal 
intensive care
2
, due to favourable anatomical factors (e.g., decreased skull thickness), 
despite very little established research to demonstrate its clinical effectiveness in the 
treatment of TBI in this age group.
28
   
The profound effect that the presence of haematomas or intra-cranial mass lesions can 
have on the cerebral NIRS parameters yielded within the context of TBI has led to this 
modality being examined as a screening tool for the presence of these lesions since the 
early 1990s.
29-34
 Primarily, these investigations examined the mean difference in optical 
density between each cerebral hemisphere (ΔOD) as a means of localising pathology or 
predicting the presence of a localised haematoma or mass lesion. Within this area of 
study, work conducted by Robertson et al.
31
 examined parameters retrieved from over 
300 patients under observation after sustaining a TBI. The primary goal of this 
investigation was to establish if cerebral NIRS using ΔOD could predict the 
development of a significant secondary mass lesion. Fifty nine patients in this cohort 
developed a secondary haematoma with 93% (n=55) of these cases identified by a 
positive ΔOD. Other similar investigations support these levels of sensitivity at 
approximately 90%,
30, 31
 with Salonia et al.
34
 producing similarly sensitivity and 
specific data in paediatric cases. NIRS therefore has exciting potential as a bedside 
screening tool for those individuals admitted after TBI to be observed for the 
development of secondary mass lesions, particularly if clinical examination is 
impractical due to sedation/general anaesthesia and if avoiding invasive intra-cranial 
monitoring is desired.  
47 
The use of NIRS in the detection of acute (primary) intra cranial haematomas would be 
most useful in the out of hospital setting, where identification of an acute mass lesion 
would lead to earlier traumatic brain injury focused resuscitation techniques alongside 
expedited transportation to specialist neurosurgical centres. The role of NIRS for the 
initial detection of haematomas within the secondary or tertiary care setting would be 
considerably more limited due to the availability of CT imaging, where axial imaging is 
available and indicated, NIRS currently does not offer an acceptable replacement or 
surrogate for these investigations on presentation of injury. However, as discussed for 
ongoing monitoring for the development of new mass lesions where serial imaging is 
not desirable or practical; a potentially useful role exists for NIRS.  
Currently, the majority of treatments implemented in the management of significant 
(moderate-severe) TBI consist of measures to normalise intra-cranial pressure (ICP) and 
maintaining an acceptable cerebral tissue perfusion pressure, with other invasive 
devices monitoring intra-cranial metabolic parameters such as cerebral tissue 
microdialysis and tissue oxygen tensor sensors. If cerebral NIRS is to provide a viable 
alternative to these established invasive monitoring technologies then clearly there 
needs to be convincing evidence that NIRS can provide clinical data that is sufficiently 
accurate to do so. As mentioned, ICP is currently a cornerstone in the management of 
TBI. In a small number of investigations NIRS-based parameters have been 
demonstrated to have a reasonably robust temporal relationship with ICP
15, 35-37 
in both 
traumatic and non-traumatic causes of intra-cranial hypertension. However, data 
regarding the sensitivity of NIRS to detect or predict changes in ICP is sparse. 
Weerakkodi et al.
35, 36
 demonstrated in two studies that changes in NIRS parameters 
during CSF infusion very strongly correlated with vasogenic slow wave rises in ICP in a 
48 
total of 59 post-TBI patients (P<0.001). A smaller investigation undertaken by Kampfl 
et al.
37
 investigated this specifically in the context of severe TBI and demonstrated that 
individuals with an ICP of greater then 25mmHg exhibited significantly different 
(reduced) NIRS parameters then those with an ICP below 25mmHg, although this only 
included data on 8 patients who were pre-selected based on their ICP. Unfortunately 
this study focused primarily on the ability of NIRS to detect cerebral hypoxia within the 
context of a raised ICP (which was reported as satisfactory) and not on the ability of 
NIRS to determine if a change in ICP has occurred and the nature of its temporal 
relationship. Budohoski et al.
15
 examined the response phasing of cerebral monitoring 
modalities to changes in arterial blood pressure (AP) and cerebral perfusion pressure 
(CPP) in 41 TBI patients and demonstrated a robust relationship between significant 
changes in ICP (>5mmHg) and NIRS-based parameters (TOI + THI) in 121 pressure 
change ‘events ‘during approximately 120 hours of multi-modal monitoring. A 
limitation of this study for supporting the concordance of ICP with NIRS was that only 
events where a significant change in NIRS parameters that followed changes in ICP 
were considered for analysis. Therefore, within the hours of monitoring data there was 
likely to have been numerous significant pressure-related events that evoked no 
demonstrable change in NIRS parameters. Consequently, it is difficult to determine a 
definitive sensitivity for changes in NIRS parameters reacting to variations in ICP.
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Author/Year Device N NIRS Ability Conclusion Comment 
Robertson et al
32        
1997
 
RunMan 
(US) 
300 
Haematoma 
development 
Intra-cranial haematomas accurately 
detected at presentation. 
Dissymmetry in optical density 
used as identifier 
Weerakkodi et 
al
36  2012 
Hamamatsu 
NIRO 200 
40 
Intracranial 
Hypertension 
Fluctuations in NIRS  parameters predictive 
of the development of vasogenic waves in 
(raised) ICP during CSF infusion studies. 
Correlation coefficient between Hb 
and OHb as a marker of the slow 
vasogenic waves of ICP. Not in 
acute setting. Difficult to translate 
findings to traumatic brain injury 
setting. 
Kampfl et al.
37
 
INVOS  
3100A 
8 
Intracranial 
Hypertention 
 
Significant difference in NIRS parameters 
between individuals with intra-cranial 
hypertension (>25mmHg) and those 
without. 
Very small investigation. 
Significant finding building on 
Weerakkodi et al, although 
patients were pre-selected as 
having a raised ICP or not. 
Leal-Noval et al
19  
2010
 
INVOS 
5100 
22 
Brain Tissue 
Oxygen 
Tension 
A robust relationship to significant changes 
in tissue oxygen tension, but not sufficiently 
sensitive to detect moderate or mild changes 
Significant number of individuals 
excluded (46%).Concludes that 
NIRS cannot be used as a 
substitute for this modality. 
Lewis et al
49 1996
 
INVOS 
3100 
10 
Jugular Bulb 
Saturation 
Poor correlation and agreement between 
modalities 
14 clinically significant episodes 
of Jugular bulb desaturation 
missed by NIRS monitoring. 
Table 3.1. Summary of Key Works 
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Collectively, such findings demonstrate that NIRS has the potential to be used in 
selected cases as a surrogate for invasive ICP measurement, although there are currently 
factors preventing this strategy from being implemented. Firstly the relationship 
between NIRS and ICP in terms of retrospective temporal/waveform analysis has been 
coupled in these reported investigations, but the extent that NIRS can be relied upon to 
detect changes in ICP (in the absence of an invasive probe) has not been established. 
Further, the precise behaviour of this relationship is not understood well enough to 
enable prospective predictions of how to interpret changes in NIRS parameters as 
changes in ICP (e.g., would a larger change in NIRS parameters reflect a more 
significant rise in ICP?). A great deal more work is required before a specific protocol 
could be developed to allow changes in NIRS activity to be directly ‘converted’ into a 
change of ICP. As mentioned above, NIRS parameters have not reliably demonstrated 
an ability to reflect true absolute values, and this is true in terms of any established 
relationship with ICP, although frequently in cases of moderate or mild TBI where 
effective clinical monitoring is not possible, it is only knowledge of a substantial change 
in values that the clinician will require. Therefore, using NIRS as a non-invasive 
alternative to ICP measurement could be feasible; however more research is required to 
better establish the nature of the relationship.       
Within the last decade a number of alternative intra-cranial/cerebral tissue monitoring 
modalities have been developed with the view of directing therapy more precisely to 
maintain the most favourable environment for neurological tissue and the most 
consistent intra-cranial homeostasis. Cerebral tissue microdialysis and brain tissue 
oxygen tension (PbtO2) are perhaps the two most noteworthy developments within this 
field. As the focus of treatment in TBI moves towards these parameters and becomes 
51 
less heavily reliant on ICP alone, it becomes increasingly important for cerebral NIRS 
to demonstrate its equivalence and effectiveness against these modalities. 
PbtO2 is an invasive modality measuring the partial pressure of oxygen in extracellular 
tissues of the brain. It is, therefore, broadly a measure of the balance of consumption 
and the availability of oxygen for aerobic respiration. A normal physiological level of 
oxygen partial pressure in the brain is approximately 25-30 mmHg.
38
 This modality has 
been established as a promising and safe monitoring modality in TBI, and PbtO2 guided 
therapy has been linked to improved patient outcome.
38, 39
 In terms of establishing the 
relationship between cerebral NIRS and PbtO2, Leal-Noval et al.
19
 in 2010 published a 
prospective observational investigation of 22 patients with severe TBI, specifically 
looking at this relationship. Each patient was observed over a 16-hour period with a 
total of almost 42,000 paired NIRS/PbtO2 data points. The study concluded that NIRS 
was reliably sensitive in detecting relatively severe cerebral hypoxia (PbtO2 <12mmHg), 
but in situations where tissue hypoxia was less severe the sensitivity of NIRS vs PbtO2 
decreased significantly. Another limitation of this investigation that must be considered 
was that 45% of the originally recruited cohort was excluded due to TBI specific factors 
(e.g., scalp haematoma, surgery or a poor NIRS signal). These authors recommended 
that the NIRS technology as it stood was not sufficiently sensitive to be used 
independently of PbtO2. Budohoski et al.
15
 juxtaposed NIRS and PbtO2 in 41 TBI 
patients and noted a concordance between modalities of approximately 77%, although 
principally the aim of this investigation was to establish the temporal relationship 
between multiple modalities of brain tissue oxidative physiology.  Within this study no 
comment was made on the clinical significance of these events and any differing 
agreement between the modalities with tissue hypoxia of differing magnitude. A largely 
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negative outcome was reported in a more recent investigation by Rosethal et al.
40
 that 
evaluated the effectiveness of NIRS technology when combined with ultrasound pulsing 
against invasive multi-modal monitoring in 18 patients with severe TBI. They 
concluded that the parameters recovered by NIRS did not correlate to PbtO2 
consistently (using the Licox® system).  
These three aforementioned studies
15, 19, 40
  utilised the Licox® (Clarke cell based) 
system for PbtO2 monitoring, without frequency domain or depth resolved NIRS data 
acquisition. To date, no study has compared these modalities using either the alternative 
systems of measuring PbtO2 or any of the data manipulation techniques discussed 
above, including better depth resolved outputs such as the TOI and THI. Future 
investigations incorporating these technical modifications may produce different and 
more conclusive results. Nonetheless, currently available cerebral NIRS devices and 
application of the technology has not yet demonstrated sufficient accuracy to be used as 
an independent surrogate for PbtO2 in TBI.   
Jugular bulb venous oxygen saturation has been a mainstream and popular method of 
measuring cerebral oxygen saturation and oxygen consumption for over two decades, 
and it has been demonstrated as a valuable tool in predicting outcome after severe 
TBI.
41-44
 The relationship and correlation of cerebral NIRS to this modality (inside and 
outside the context of TBI) has been reported with positive results in multiple small 
observational investigations in children.
45-47
  As such, evidence for how changes in 
cerebral NIRS parameters reflect and predict changes in jugular bulb oximetry is sparse, 
particularly within the context of TBI. A small early prospective observational study 
conducted by Tateishi et al.
47
 indicated a positive correlation in the majority of their 
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subjects, although only 10 cases were considered and of these only 4 were cases of TBI. 
A subsequent investigation carried out by Lewis et al.
48
 (10 TBI patients), which 
incorporated a greater number of paired measurements and recorded clinically 
significant episodes of jugular bulb desaturation, reported very poor correlation between 
the modalities. This study concluded that cerebral NIRS was not at all useful in 
predicting changes in jugular bulb saturation. Both of these investigations were very 
limited in terms of number of patients, and the NIRS technology available at the time 
(1995-6) did not make use of more recent advances in depth resolved parameters. 
Therefore, new studies that make use of significant recent advances in NIRS technology 
and analysis are needed to provide evidence regarding the ability of cerebral NIRS to 
predict changes in jugular bulb venous saturation. 
At this time there are very few clinical studies assessing the relationship between 
cerebral microdialysis and NIRS parameters. Murine models provide encouraging initial 
data regarding the ability of NIRS to predict changes in lactate-to-pyruvate ratios in 
cerebral tissue,
49
 although subsequent clinical work within the context of TBI reported 
results to the contrary. Specifically, an investigation by Tachtsidis et al.
50
 involving 8 
TBI patients compared broadband NIRS parameters targeting cytochrome-oxidase with 
tissue ratios of lactate-to-pyruvate in cerebral tissue harvested via microdialysis. The 
reaction of these parameters to changes in blood CO2 and O2 was observed, yet the 
authors found no correlation or agreement between these two modalities of cerebral 
metabolism measurement.   
Unfortunately, as with many other monitoring modalities within the field of brain injury 
medicine, there is very limited evidence to support the ability of NIRS to predict 
54 
outcome after injury. Although frequently referred to in limited clinical 
investigations,
17-19, 29-37
 no substantial prospective investigation provides useful 
information regarding how NIRS parameters can be used to predict the eventual impact 
of a particular injury. This in particular provides an opportunity for very meaningful 
investigations to be undertaken in the future.    
3.7 Future Directions for NIRS 
The recent developments in computational modelling of NIRS (as discussed earlier in 
this review) and the integration of NIRS-based parameters into subject specific imaging 
currently represents an exciting and useful expansion of optical monitoring in brain 
pathology.
51
  Using contemporaneous patient images (e.g., CT, MR) and integrating the 
information that imaging provides (e.g., specific information regarding tissue 
thicknesses and the location of neurological structures) a far more sensitive and relevant 
interpretation can be made of the parameters recovered by NIRS. This technology 
exists, and initial pre-clinical modelling is promising.
8, 9, 51
 
In order to determine the future role of cerebral NIRS in the management of TBI, work 
needs to be undertaken to establish a greater understanding of the relationship between 
NIRS-based monitoring and the other established modalities. Through these 
investigations the significance of a change in NIRS parameters and its implications can 
be better interpreted and understood. To achieve this a large prospective observational 
investigation comparing cerebral NIRS with established invasive monitoring methods is 
needed, which incorporates validated outcome measures at key time points in the patient 
journey. Should data from such a study be available, the justification of interventional 
55 
investigations utilising NIRS technology can be justified. Table 2 summarises the 
currently viable roles for NIRS based monitoring within the context of traumatic brain 
injury based on the evidence presented.  
 
Table 3.2. Summary of current useful application of NIRS 
Recent technological advances have been made in the delivery of NIR light and its 
detection in biological tissues, rather than interoperating the conventional NIRS 
parameters in a more eloquent manner (combining it with other modalities). Of note are 
Diffuse NIR Correlation Spectroscopy (DCS) and Ultrasound pulsed conventional 
NIRS (UP-NIRS).  DCS observes the very subtle fluctuations in light scatter that are 
observed during NIR detection through tissue (largely caused by the movement of the 
target chromophores within tissue). Its application provides derived values for tissue 
perfusion and blood flow
52
 – as opposed to total Hb and the saturation of that Hb with 
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conventional NIRS. This technique has been largely pioneered at the University of 
Pennsylvania, USA.
53
 The advantages of this technique are clear, as information 
regarding the supply/quantity of blood actually reaching the tissue and the saturation of 
the transported Hb with oxygen gives far more specific feedback as to the effects of any 
intervention or therapy. Further, it also supplies the clinician with a more detailed idea 
as to how ICP and cerebral perfusion are affecting oxygen delivery at the capillary 
level. No current clinical evidence has been published using this method, largely due to 
the lack of commercial availability of this equipment and on-going refinements in the 
technique. Nevertheless DCS poses an exciting prospect in the field of non-invasive 
monitoring in TBI.  
A similar adaptation of NIR technology to estimate values of flow, perfusion and blood 
movement using ultrasound tagging of NIR parameters has also been developed and 
demonstrates encouraging initial results in healthy volunteers.
54
 The advantages of this 
method of parameter recovery are very similar to those highlighted by DCS. Another 
positive facet of this particular development in NIR monitoring is that a commercially 
available standalone device is currently available (C-Flow™ – Ornim Medical, MA 
USA). Peer review publications regarding clinical implementation and effectiveness are 
not yet available using this device, although given the availability of the technology this 
progression in NIR imaging is another exciting avenue for development in the field of 
TBI.      
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3.8 Conclusions 
On balance, currently NIRS technology has the potential to provide a useful non-
invasive adjunct to mainstream monitoring in neurological trauma. The application for 
which the most evidential support exists (in its current technical state) is for the 
detection of intra-cranial (space occupying) haematomas. At present there is not 
sufficient evidence to support its use as a surrogate or replacement for any invasive 
monitoring modality, as efforts to test the modalities ability to detect significant changes 
in intra-cranial pressure, brain tissue oxygen tension or jugular bulb saturation have not 
yielded sufficiently consistent results.   
However, the technology is improving rapidly, with introductions of novel methods of 
data acquisition and analysis and its mergence with other imaging modalities. These 
exciting developments have the potential to enhance the utility of NIRS as a non-
invasive neurological monitoring tool that can provide information that is as useful to 
the clinician as currently available invasive modalities.   
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CHAPTER 4:  RELIABLE CEREBRAL 
HAEMODYNAMIC SIGNALS DETECTED BY NEAR 
INFRA-RED SPECTROSCOPY; REDUCTION IN SKIN 
BLOOD FLOW HAS MINIMAL EFFECT 
Hypothesis 
Point of care frequency domain near infra-red has the ability to detect changes specific 
to the brain during Valsalva manourve, and manipulatuion of superficial tissue 
perfusion will not significantly alter the nature of the paramters recovered from the 
targeted cerebral tissues.   
Abstract 
Background: There is debate over the reliability of near infra-red spectroscopy (NIRS) 
and its clinical use in traumatic brain injury (TBI). A Valsalva manoeuvre (VM) elicits 
a reduction in cerebral perfusion and a rise in intra-cranial pressure, providing a 
clinically relevant cerebral haemodynamic model. Aims: To test the ability of an 
unmodified clinically viable Frequency Domain (FD) NIRS device to measure changes 
in brain saturation during a VM independent of superficial tissue activity. Methods: 
Differences between NIRS parameters recovered from the brain and extra-cranial 
tissues (of the head) in healthy individuals undertaking a series of VMs under laboratory 
conditions. The effect of reducing blood flow in the scalp were examined by the 
infiltration of local anaesthetic containing epinephrine and then repeating the protocol. 
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Results:  Six healthy individuals performed standing VMs with NIRS targeted at brain 
and facial somatic tissue (zygoma). Five of these individuals performed further VMs 
after infiltrating 2% xylocaine/1:100,000 epinephrine into scalp tissue beneath the 
probes (vaso-constrictor). Clear differences were observed between the NIRS responses 
seen from somatic tissue to those acquired from brain-targeted NIRS (P<0.012). No 
significant change in brain-targeted NIRS during VM was observed after 
vasoconstrictor. Baseline values for cerebral oxygen saturation (%) were highly 
variable. The standard deviation (8.1-11.4%) was greater than the highest mean changes 
induced during VM. Conclusion: The FD NIRS device tested detects significant 
physiological changes in brain tissue, independent of extra-cranial blood flow changes. 
Baseline values for cerebral saturation are highly variable.  
4.1 Introduction 
Near infra-red spectroscopy (NIRS) has long represented an attractive non-invasive 
monitoring modality for the injured brain.
1
 However, concerns exist regarding the 
validity and reliability of output parameters, produced by currently available technology 
within the context of neurological pathology. Specifically, a lack of evidence exists to 
support the ability of NIRS to detect changes in intra-cranial metabolic activity with 
sufficient accuracy to be used to direct therapy independently within the context of 
traumatic brain injury (TBI).
2
 In addition, numerous investigations have raised concerns 
regarding the contamination of the NIRS parameters by vascular haemodynamics in 
superficial extra-cranial tissue (i.e. scalp and skin).
3-5
 This concern exists to such an 
extent that the usefulness of NIRS to reliably detect brain metabolic activity in adults 
has been debated and has limited the use of NIRS in the monitoring of TBI.
6
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Significant work has been undertaken within the field of medical optics to improve the 
resolution and consistencies of NIRS/optical arrays via a number of novel methods. 
Particularly the development of frequency and time domain devices, allowing more 
accurate quantitative analysis by observing phase shift and time of photon flight through 
tissues (TD). Diffuse Optical Tomography (DOT) is an expanded NIRS concept in 
which a large array of sources and detectors are placed in a grid configuration across the 
entire scalp. Investigations utilising these enhanced technologies clinically have been 
undertaken
7
, with success. Unfortunately cost, the requirement for extensive 
modification and practical difficulties in the application of the devices have led to a 
poor uptake of these technologies within the adult clinical context.
2
    
Recent studies have attempted to quantify this superficial contamination issue of 
clinically viable Point of Care (POC) NIRS devices via the occlusion of blood flow to 
the forehead.
6,8
 One such study using pressurised pneumatic bands placed around the 
forehead of healthy volunteers reported that the reduction of superficial/extra-cranial 
blood flow has a significant effect (between approximately 6 and 16%) on detected 
cerebral oximetry parameters across a range of commercially available NIRS devices.
8
 
A limitation of this study was that only resting state parameters were recovered, and the 
absolute reduction in tissue perfusion was not quantified. An alternative method of 
investigating the effects of suppressing haemoglobin signal in the superficial tissues on 
NIRS parameters received from cerebral tissue could be infiltration of the forehead 
tissue directly underneath the applied NIRS probes with a mixture of vasopressor and 
local anaesthetic agent. Reduction in skin blood flow via the injection of a vasopressor 
agent before and after the acquisition of NIRS signals during a Valsalva manoeuvre 
would provide a useful method of observing and quantifying the effects of 
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cutaneous/scalp tissue changes on NIRS output parameters. Fundamental advantages of 
this technique include the absence of pressure deforming flexible NIRS skin probes and 
the variable effect that that may have between probe placements, and the ability to 
formally quantify the reduction in perfusion that has occurred as a result of application 
(via capillary refill observation and laser Doppler). Evaluation of the injected substance 
in other historical investigations indicates that it elicits a reduction in skin blood flow 
equivalent to approximately 44%, with a peak effect occurring 8 minutes after 
administration, and the effect lasting for approximately 30-60 minutes.
9
 Further, laser 
Doppler assessment of flow can take place over the same area of skin from which NIRS 
parameters are recovered. 
The Valsalva manoeuvre (VM) involves forced respiratory expiration against a closed 
glottis (essentially straining), resulting in a marked increase in intra-thoracic pressure 
causing impaired venous return via the great thoracic veins. This in turn results in a rise 
in intra-cranial pressure (ICP) due to impaired venous outflow, and a decrease in blood 
pressure due to reduced cardiac venous return (after an initial brief increase prior to 
cardiac filling being compromised). Due to its marked effect on intra-cranial physiology 
this manoeuvre provides a predictable and consistent means by which to test the ability 
of NIRS to detect intra-cranial haemodynamics.
10
 The VM also provides a useful and 
reproducible method of simulating a rapid rise in intra-cranial pressure together with a 
fall in cerebral perfusion pressure (a common scenario in acute TBI). In order for 
cerebral NIRS to prove useful within the context of TBI, it should be able to 
demonstrate an ability to consistently observe these changes in physiology and 
differentiate metabolic activity within the brain from that on the skin.  
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The brain differs from head and neck somatic tissue in terms of both its basal metabolic 
demands, direct vascular/energy coupling and its containment within the ridged 
calvarium (skull). During a VM, initial venous congestion and the accompanying rise in 
ICP followed by a fall in blood pressure will theoretically cause a marked decrease in 
the saturation (oxygenated/ deoxygenated components) of the available haemoglobin 
(Hb). This is due to the ongoing high-energy demands of the brain at rest extracting 
more oxygen from the congested capillary beds. In contrast, extra-cranial somatic 
tissues (still within the head and neck region, sharing broadly the same vascular 
network) have a relatively low basal metabolic demand, therefore a far less marked 
decrease in Hb saturation will theoretically be observed during a VM. In addition to 
this, the skin tissue perfusion pressure will not be compromised in the same way as the 
intra-cranial tissue during the VM. Specifically, the rise in ICP reduces the net perfusion 
into the brain tissue whereas no increase in external pressure exists to influence 
haemodynamics in the skin or muscle tissues in the same way. Recent studies targeting 
advanced time domain NIRS devices specifically at superficial tissue reported results 
supporting this model 
11
 (predominant increase in saturation of superficial tissue during 
VM), although it should be noted that a maximum exertion VM was not employed in 
the testing protocol, and therefore a less marked cerebral response was observed.   
4.2 Aims 
Against this background the aims of the current study were:  
1. To investigate the ability of a commercially available POC frequency domain NIRS 
device to reliably detect changes in intra-cranial physiology elicited by performing 
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maximum effort VMs in healthy individuals. A significant difference in the 
proportions of oxygenated and deoxygenated Hb (within the field of NIRS 
acquisition) between probes targeted towards brain tissue and resting somatic tissue 
(close to the brain) would indicate that the majority of the signal derived originated 
from deeper (cerebral) tissue and was representative of its more robust metabolic 
requirements.   
2. To explore the extent to which suppressing surface tissue vascular activity modifies 
the response detected by NIRS during the Valsalva manoeuvres.  
Activity with these superficial tissues certainly has an impact on NIRS output 
parameters
8
, although we hypothesise that this influence is not sufficient to prohibit an 
overall detection of signature brain physiology. Therefore manipulation of the blood 
flow to these superficial tissues should not have significant consequences on the gross 
morphology of output parameters.  
4.3 Methods 
4.3.1 Participants 
Healthy Volunteers recruited from within the university took part in this study after 
providing their informed written consent. The study conformed to the Declaration of 
Helsinki and was approved by the University of Birmingham Research Ethics Board 
(Ref.: ERN_30-1031). Individuals recruited had no significant prior medical history.  
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4.3.2 Design 
A prospective healthy volunteer study, conducted under controlled laboratory 
conditions.  
4.3.3 Equipment  
The ISS OptiplexTS™ is a frequency domain NIRS device produced by ISS, Illinois 
USA. A key feature of this device is the use of frequency modulation to determine 
scatter and migration of photons within tissue, with less reliance on assumption for 
these values. Therefore the device has the potential to provide more reliable readings for 
the absolute values of oxygenated and deoxygenated haemoglobin within tissues than 
other available devices dependant on spatially resolved parameters only.   
 In order to maximise clinical relevance and translatability, focus will be maintained on 
commercially available device configuration, with no post purchase modification of the 
skin probe or processing hardware. The standard 2 light frequencies (680 & 830nm) 
employed by the device will be maintained along with the device standard NIRS 
source/detector spacing (fig. 1), specifically employing a single detector with 4 
individual sources at 30, 35, 40 and 45mm distances (each emitting the 2 device 
standard wavelengths). Simulation of this particular wavelength/spacing array utilising 
an open source software package
12
 (NIRFAST – MATLAB code based software 
package designed specifically to model NIR light transport in tissue) indicated that peak 
sensitivity of this device at 8mm, with deep data resolution possible from a depth of 
approximately half the source detector separation distance. For simplicity and maximum 
clinical translation we will focus analysis on Hb saturation only, this was largely due to 
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the fact that information from both key chromophores are considered (oxygenated and 
deoxygenated).   
 
Figure 4.1. Computational representation of the ISS NIRS source detector layout 
4.3.4 Procedure 
Participants performed a series of standing VMs under controlled laboratory conditions 
whilst undergoing brain targeted NIRS over the prefrontal cortex. Following these VMs, 
probes were placed along the line of the zygomatic arch (Fig. 2) and VMs were repeated 
while the NIRS device was targeting this non-neurological tissue. Specific instruction 
regarding the technique required to perform the Valsalva was given to each individual, 
along with 1-2 rehearsal manoeuvres. The adequacy and consistency of each VM was 
monitored using contemporaneous beat-to-beat blood pressure monitoring via finger 
photoplethysmography (Portapres, Finapres Medical Systems, The Netherlands), with a 
clear and classic phased response representing a satisfactory effort. Individuals were 
requested to make a maximal effort manoeuvre for a total of 10 seconds.  A series of 2-3 
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consecutive manoeuvres was performed in each individual to ensure consistency in the 
response. Sufficient time was allowed for full recovery of the blood pressure to baseline 
levels prior to commencing any further manoeuvres. 
For the brain tissue directed observations, NIRS probes were placed on either side of the 
forehead approximately 2 cm above the superior orbital ridge with the field of 
acquisition centred in the mid-pupillary line. Prior to commencing each investigation 
both channel probes of the ISS OptiplexTS™ were calibrated using the same 
homogenous gel tissue phantom (device specific).   
For NIRS acquisition from somatic tissue, references were taken from participant 
specific and library T1 weighted MR scans to determine an optimal position of the 
probe as close to the scalp as possible, whilst avoiding any possible signal acquisition 
from the brain substance or air sinuses (Fig. 2). Placement of the probe along the line of 
the zygoma was selected as an appropriate position; imaging indicated that the 
maximum accurate acquisition depth of the ISS OptiplexTS™ system (2 cm) would 
yield data from a mixture of bone and muscle (Zygomatic arch and pterigoid muscles) 
tissue only, avoiding completely the maxillary air sinus and the oral cavity. Careful 
examination of axial imaging demonstrates the selecting a consistent site of probe 
placement (between individuals) that does not incorporate air, major blood vessels or 
the orbit required a great deal of consideration.   
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Figure 4.2. Somatic tissue acquisition, participant specific imaging 
A subgroup of participants underwent infiltration of the forehead tissue (skin/scalp) 
directly underneath the applied NIRS probes with a mixture of vaso-constrictor and 
local anaesthetic agent. Approximately 1.5-2 mL of 2% xylocaine with 1:100,000 
epinephrine was infiltrated into the forehead skin under close observation. Probes were 
then applied after the capillary refill time at the area of infiltration exceeded 4 seconds. 
Skin perfusion pre and post application of the xylocaine with epinephrine was also 
formally assessed using laser-Doppler (DRT4, Moor Instruments Ltd, UK) to accurately 
quantify the effects of the vaso-constrictive agent.  
4.3.5 Data Analysis 
Graphic plotting of the parameters outputted by the ISS OptiplexTS™ allowed careful 
comparison of the morphology of each recorded response. The mean change in 
saturation recorded during each Valsalva was assessed relative to baseline, together with 
the direction of that change (positive or negative).  
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After discussion with institutional medical statisticians a comparison of the responses 
was then made using a non-parametric Wilcoxon signed ranks test. This was selected 
due to the non-parametric nature of the data (after specific testing) together with the 
relatively modest size of the data set.  
4.4 Results 
The six healthy volunteers performed a collective total of 48 maximal exertion standing 
VMs. Of these 48 manoeuvres, 31 were undertaken with NIRS probes directed at 
neurological tissue (placement on the forehead as described), with 17 being performed 
with NIRS probes directed at somatic tissue within the facial skeleton. All individuals 
who had NIRS parameters recovered from somatic tissue also had neurological readings 
recovered. Readings were taken bilaterally and simultaneously from NIRS probes on 
each side of the forehead and facial skeleton, each feeding an individual input channel 
into the NIRS device (Channel A and B, left and right side of the head, respectively).  
Of the original six participants, five performed a further series of 22 VMs after the 
infiltration of xylocaine/epinephrine into the cutaneous and sub cutaneous tissues at the 
prefrontal site beneath the NIRS probes. Photographic documentation of the site of 
vasopressor infiltration ensured accurate placement of the probes between pre and post 
measures. Data from one individual was excluded due to inconsistent data being 
retrieved by the NIRS device, thought possibly due to the effects of needle trauma on 
the subcutaneous tissues. Thus, a total of 19 manoeuvres in 4 individuals with infiltrated 
vasopressor were considered.    
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Figure 4.3. A representative illustration from one participant of the effect of vasoconstrictor on 
laser Doppler parameters during a 10-s Valsalva recorded on forehead tissue following injection 
(right side) compared to that recorded from somatic tissue (left side). Dotted lines represent period 
of maximal Valsalva 
All VMs performed proved consistent and accurate in terms of the 4-phase blood 
pressure response (Fig. 3) as observed by beat-to-beat monitoring. During the observed 
VMs the difference in recovered parameters observed in both channels from 
neurological (forehead) and somatic (zygoma) tissue were statistically significant 
(P=0.012), with saturation decreasing during the VM at the forehead and increasing in 
somatic tissue (Tables 1 and 2, see also Fig. 3). 
  
76 
Brain targeted NIRS Left side Saturation 
 (Channel A) 
Right side Saturation 
(Channel B) 
Range -6.7 to +2.68% -8.04% to +2.3% 
Mean -1.59% -1.7% 
Median -1.7% -1.73% 
 
Table 4.1. Summary of mean saturation changes observed from measured forehead sites (left and 
right side) during a 10-s maximal Valsalva manoeuvre . Mean values calculated from 31 Valsalva 
manoeuvres 
Somatic targeted NIRS Left side Saturation 
(Channel A) 
Right side Saturation 
(Channel B) 
Range -1.31 to +10.6% +1.79 to +8.27% 
Mean +4.54% +3.52 
Median +5.02% +3.19% 
 
Table 4.2. Summary of mean saturation changes observed from measured somatic site during a 10-
s maximal Valsalva manoeuvre. Mean values calculated from 17 Valsalva manoeuvres 
After the application of vasoconstrictor, largely similar results were yielded in terms of 
response morphology during the VM (Table 3, see also Fig 4). No statistically 
significant differences were observed between the maximum changes in saturation from 
the brain targeted NIRS pre and post infiltration (P=0.123 Channel A, P=0.093 Channel 
B). The effect of infiltration on the skin was quantified by laser Doppler and was found 
to be largely in keeping with previous reports in the literature (Fig. 2), with a consistent 
decrease in flux observed between 40 and 85% (mean±SD: 55 ±15%). 
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Figure 4.4. A representative illustration of oxygen saturation derived by the ISS NIRS system from 
one participant during 10-s Valsalva manoeuvres with NIRS targeted at brain (pre and post 
injection of vasoconstrictor) and somatic tissue. Dotted lines represent period of maximal Valsalva. 
Brain Directed NIRS 
After infiltrating skin 
vasoconstrictor 
Left side Saturation 
(Channel A) 
Right side Saturation 
(Channel B) 
Range -4.4% to +1.85% -8.11% to +0.25% 
Mean -1.08% -2.06% 
Median -1.43% -1.38% 
 
Table 4.3: Summary of mean saturation changes observed from measured forehead sites (left and 
right side) during a 10-s Valsalva manoeuvre following infiltration of vaso-constrictor. Mean values 
calculated from 19 Valsalva manoeuvres 
In terms of the total haemoglobin within the field of NIRS acquisition (as opposed to 
saturation), a statistically significant difference was observed between pre and post 
infiltration of the xylocaine/epinephrine (P=0.017 Channel A, P=0.028 Channel B). 
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This demonstrated a definite effect of the vasoconstriction on the absolute output 
parameters, although the nature of the response during the desaturation process of the 
VM was not altered (Fig.4). 
Finally, the variability observed in baseline brain targeted NIRS parameters was 
marked. With the standard deviation of baseline readings exceeding the maximum 
change observed during VM. The data presented in Tables 4 and 5 represent an average 
taken from a steady 10-s baseline recording prior to each Valsalva. Interestingly the 
infiltration of xylocaine and epinephrine solution markedly reduced the standard 
deviation of baseline saturation parameters recovered from one channel, with a modest 
reduction in the other (Table 4+5).  
Baseline values   
(Sat Forehead) 
Left side Saturation 
(Channel A) 
Right side Saturation 
(Channel B) 
Range 38.82 to 73.15% 38.59 to 93.12% 
Mean 65.33% 68.4% 
Median 63.26% 66.88% 
Standard Deviation 8.16% 11.48% 
 
Table 4.4. Variability observed in baseline neurologically targeted NIRS with and without vaso-
constrictor 
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Baseline values  
(Sat Forehead Post Vaso-Constrictor) 
Left side Saturation 
(Channel A) 
Right side Saturation 
(Channel B) 
Range 61.39% to 70.69% 51.09-71.82% 
Mean 65.33% 63.3% 
Median 65.18% 66.7% 
Standard Deviation 2.69% 7.8% 
 
Table 4.5. Variability observed in baseline neurologically targeted NIRS 
with and without vaso-constrictor 
4.5 Discussion 
The contamination of NIRS signal from the superficial tissue (especially in task 
involving subtle shifts in brain physiology) has been demonstrated as a cause for 
discrepancy between the changes detected by NIRS and metabolic imaging.
13
 However 
these investigations often refer to the detection of subtle changes reflecting functional 
activity within the cortex (verbal fluency task, or tests of visual stimulus). As a clinical 
monitoring tool within the context of major brain injury it could be suggested that the 
ability to clearly resolve frank physiological changes was more important. Current 
invasive monitoring techniques implemented within the clinical setting detect frank 
changes in need of intervention (hypoxia, mass lesions, ischemia, and increases in ICP), 
indicating that levels of resolution required for the clinical management of brain injury 
may not require the degree of sensitivity of functional imaging.  
In order for cerebral NIRS to be established as a credible and independent method of 
monitoring brain pathology in a clinical environment, its ability to reliably detect these 
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clinically significant changes in intra-cranial physiology regardless of vascular activity 
in the overlying skin and scalp tissues must be robustly tested and proven accurate . To 
this effect the VM is a reproducible model in which to simulate clinically significant 
changes in cerebral saturation (leading to brain tissue compromise) in order to test 
relevant monitoring modalities, based on specific investigations utilising it, and 
investigations observing activity due to similar vascular/respiratory phenomina
13-18
   
Tsubaki et al.
18
 performed an investigation examining the effect of the marked shift in 
systemic blood pressure during VM on cerebral NIRS parameters recovered from 
apparently deep (brain) and superficial tissues, utilising a variety of source detector 
separation distances although not moving the probe to an area where derivation of brain 
signal was impossible. They reported that NIRS parameters were both highly influenced 
by changes in blood pressure caused by VM, observing a significant difference between 
parameters recovered from brain and superficial tissue occurs during Valsalva.  This not 
only highlights the importance of ensuring the uniformity of the blood pressure 
response in this experiment, but supports our hypothesis that the Valsalva is a valuable 
tool for differentiating activity between the brain and overlying superficial tissues.      
As discussed, for the purposes of monitoring individuals with TBI, it could be argued 
that the ability of any clinically viable NIRS system to detect small and subtle changes 
is less important than its ability to detect clinically significant shifts in tissue 
physiology. In practice, the care of these individuals is more concerned with gross 
homeostasis rather than with small fluctuations in tissue saturation. For these reasons 
we argue that the findings of the present study has demonstrated that this type of POC 
NIRS device in its as purchased configuration has the ability to differentiate major 
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changes in brain tissue saturation independent of signal contamination from the 
overlying scalp tissues across a group.  
The ability of the device to detect neurological changes in tissue saturation are well 
represented in Figure 3, where during a Valsalva manoeuvre a largely positive 
(increase) change in saturation is observed in somatic tissue, with a largely negative 
(reduction) change being observed at the forehead site. These observations follow our 
physiological hypothesis of a metabolically active tissue within an environment of 
increasing pressure and decreasing perfusion, as opposed to a less metabolically active 
tissue under atmospheric pressure. The relationship of these observed changes was not 
altered significantly after the application of a potent vaso-constrictive agent into the skin 
overlying the NIRS target (pre-frontal cortical surface). We feel this demonstrates that 
although superficial tissues will always contribute to the output parameters generated by 
cerebral NIRS devices (as we observed with the change in baseline values for total 
haemoglobin within the field of acquisition after epinephrine injection), the neurological 
effects of the VM were still clearly evident.   
These abilities are clearly very important, a previous investigation undertaken by Al-
Rawi et al. 
19
 demonstrated that a commercially available continuous wave device had 
the ability to detect changes in oxygenation from tissue supplied specifically by the 
internal carotid artery (intra-cranial/brain tissue) with an encouraging sensitivity of 
~87.5%, although these peri-operative investigations were in effect resting state, and did 
not directly consider the effect of superficial tissue blood flow on masking the effects of 
physiological changes within the brain itself.  
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In order for cerebral NIRS to be established as an independent means of monitoring 
cerebral physiology in acute clinical care (particularly TBI), the interpretation of the 
baseline and the initial absolute output value is critical.
20
 At first clinical contact with an 
unresponsive patient, prior to undertaking imaging studies or invasive monitoring (or in 
the absence of this information), the baseline output NIRS parameters will be the only 
objective measure of brain health at that point. Reliability on ‘trend only’ monitoring 
within this context has significant limitations. For example, any change in the 
parameters cannot easily be interpreted as an improvement or a deterioration that 
requires clinical intervention, as the starting point is unknown. A concerning finding in 
our investigation is the inconsistency of baseline NIRS parameters. Data from clinical 
observational studies has shown that a decrease in NIRS detected brain saturation of 
approximately 16%
13,15,17
 represent a clinically significant fall, with consequences 
regarding brain tissue health and poor clinical outcome. The mean response observed 
during our investigation was a saturation fall of 8.55% during Valsalva. With these 
figures in mind a standard deviation of 8.16-11.48% (Table 4) suggests that the baseline 
measurements observed are not sufficiently consistent to be useful clinically. Improved 
methods of absolute quantification of the tissue chromophores (oxygenated and 
deoxygenated Hb) are clearly required and have been the subject of investigation for 
some time.
21
 This observation is important as the FD parameter recovery technique 
employed by this device was specifically developed to improve quantitative accuracy
22
, 
and the individual outputs from this device specify quantities of each chromophore 
within the field of NIRS acquisition.    
Interestingly, the application of a vaso-constrictive agent into the superficial tissues 
seemed to have an effect on the consistency of baseline saturation parameters (reduction 
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in standard deviation). While the modest numbers of individuals in this investigation 
prohibit any definite conclusions to be drawn from this particular observations, it does 
indicate that a reduction in superficial tissue perfusion, or reduction of the proportion of 
signal from the superficial tissue, may prove useful in future NIRS system development 
in allowing more consistent quantitative baseline measurements to be obtained from 
cerebral NIRS. 
4.6 Conclusions 
Commercially available FD NIRS devices are capable of reliably detecting changes in 
cerebral vascular physiology elicited by a VM, and the ability of the device to detect 
these changes is not significantly impaired by manipulation of the vascular activity in 
the superficial (scalp) tissues.  
However, the baseline values for neurologically targeted NIRS are highly variable, and 
are unlikely to be sufficiently consistent to establish baseline parameters within a 
clinical environment. A future target for NIRS research could be to identify key 
influences on NIRS baseline variability, and what (if any) steps can be taken to develop 
methods of parameter recovery that are less susceptible to these variations.  
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CHAPTER 5:  CEREBRAL NEAR INFRA-RED 
SPECTROSCOPY; CAN AVAILABLE POINT OF CARE 
DEVICES MATCH FUNCTIONAL MAGNETIC 
RESONANCE IMAGING IN PREDICTING 
PHYSIOLOGICAL CHANGES?  
Hypothesis 
Point of care near infrared spectroscopy has equibilent abilities to functional magnetic 
resonance imaging (blood oxygen load dependant sequence) in detecting changes 
induced by the clinically relevant physiological manauvers voluntary hyperventilation 
and Valsalva.  
Abstract 
Background: Point of care Near Infra-Red Spectroscopy (NIRS) devices have the 
potential to contribute significantly to the care of traumatic brain injury patients. 
Currently concerns exist regarding the ability of these devices to provide reliable 
observational parameters, particularly in the acute care setting. Frequency domain (FD) 
NIRS devices offer the potential for more quantitatively accurate NIRS observation. 
Aims: To compare the abilities of a clinically viable point of care FD NIRS device in 
detecting changes in brain physiology (independent of haemodynamic activity within 
the superficial scalp tissue) with functional magnetic resonance imaging. Methods: 
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Healthy individuals performed a series of Valsalva manoeuvres (VM) and 1-min 
periods of voluntary hyperventilation to induce changes in intra- and extra-cranial 
haemodynamics whilst under separate observation by FD NIRS and fMRI (3T Philips 
Achieva). Results: Nine individuals completed the clinical protocol (6m, age 21-40). 
During the VMs, brain and extra cranial tissue targeted signal were significantly 
different in both fMRI and NIRS (p=0.00025 and 0.00115 respectively) during VM, 
with clear agreement (P=0.22) between modalities. This indicates that both were equally 
good as differentiating between brain and extra cranial tissue. Robust cross correlation 
of parameters was also observed in observations made during VM and hyperventilation. 
Conclusion: Observations made by this FD cerebral NIRS device are comparable with 
fMRI in its ability to resolve haemodynamic activity from the brain surface.   
5.1 Background   
Since its clinical introduction cerebral near infra-red spectroscopy (NIRS) has 
developed into an exciting and attractive method of monitoring brain tissue in a variety 
of clinical contexts. Near infra-red light is of particular interest to medicine, due to the 
relative translucence of biological tissue to its wavelength, but critically its absorbance 
by key biological molecules (chromophores) such as oxygenated and deoxygenated 
haemoglobin (Hb) and cytochrome-oxidase. It employs similar technology to pulse 
oximetry (utilised widely in clinical practice) in that it utilises NIR light, features a light 
source and light detector, and is non-invasive. Light is transmitted through tissues, with 
absorbance reflecting specific concentrations of the target chromophores. The 
chromophores commonly (but not exclusively) targeted in clinical application are 
oxygenated and deoxygenated Hb, with output parameters either directly reflecting 
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levels of each of these (and their combined total) or the percentage of a ratio based on 
their relative concentrations (Hb saturation).   
 
Figure 5.1. NIRS Concept Illustrated 
Unfortunately, despite relatively low cost, ease of use and non-invasive nature the use 
of NIRS within the context of traumatic brain injury (TBI) care (one of its most logical 
potential applications) is limited, and it been deemed not sufficiently consistent and 
accurate for these purposes 
1,2
.  
Cerebral NIRS is easily applied, involves limited user training, with minimal operator-
to-operator variability
3
, and once applied will yield data regarding oxygenated and 
deoxygenated haemoglobin content of tissues at a specific target depth (sufficient to 
observe the surface of the adult brain). Currently one of the most established uses for 
cerebral NIRS (in adult clinical practise) is in the monitoring of cerebral tissue 
oxygenation during cardio-respiratory bypass surgery where brain tissue perfusion may 
be compromised, and its popularity is increasing
1
. There is significant evidence to 
support that the manipulation of physiological parameters to maintain a cerebral tissue 
oxygen saturation of no less than 13% below the initial baseline reduces the risk of 
neurological injury and deficit during these procedures
4,5,6
.  
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Historically the parameter recovery techniques employed in commercially available 
NIRS devices are specified as being able to identify changes from baseline parameters 
only
7
, this is largely due to the inability of these techniques to derive absolute 
quantitative measurements. The reasons for this are numerous, however the fact that 
tissue scatter properties (and therefore the path of detected photons) are based largely on 
assumption is an important contributor in many devices. Therefore, individual baseline 
parameters are highly variable and less useful clinically, which is of a particular 
disadvantage to the modality within the context of acute care and first patient contact.  
This has been confirmed to a certain extent by investigations comparing cerebral NIRS 
with traditional invasive monitoring techniques within the context of TBI, 
demonstrating that further work is needed to allow NIRS to be utilised as an 
independent method of monitoring the brain within the context of TBI
8
. Refinement in 
both the technology and techniques is ongoing, and research within the field is getting 
closer to becoming a main stream method of cerebral monitoring in TBI
1,2
.   
Various clinical protocols involving respiratory manipulation have been utilised to 
induce physiological responses within brain tissue, and these are important tools for the 
validation of devices designed to monitor cerebral activity. Voluntary hyperventilation 
can be used to induce cerebral vasoconstriction observable by NIRS
9
 (due to the 
resultant increase in plasma pH). The Valsalva manoeuvre (Fig. 2) involves forced 
expiration against a closed glottis, leading to a subsequent increase in intra-thoracic and 
intra-cranial pressure with a concurrent fall in blood pressure due to a reduction in 
venous return to the heart (leading to a reduction in cerebral perfusion). This can be 
utilised to simulate rising intra-cranial pressure with reduced perfusion and venous 
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congestion
10
. Both of these techniques are easily performed, with appropriate 
monitoring of end-tidal gas composition and beat-to-beat blood pressure they can be 
consistently reproduced, providing predictable changes in physiology suitable for the 
validation of cerebral tissue monitoring modalities.    
The Valsalva manoeuvre is an important tool in these situations as it induces a 
separation in physiological activity (on demand) between the superficial extra-cranial 
tissue and the underlying brain
11
. Specifically, during the Valsalva, the skin and 
superficial tissues experience venous connection and a pooling of blood within their 
capillary network. As their metabolic demand during the resting state is theoretically 
negligible
12
, the relative saturation of the tissue increases. Conversely during the same 
period within the confines of the skull, venous conjunction leads to an increase in intra 
cranial pressure and reduced cerebral perfusion, this combined with a fall in blood 
pressure and the brain’s considerable metabolic demands leads to a relative decrease in 
tissue saturation
13
.        
 
Figure 5.2. Principles of the Valsalva Illustrated 
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Functional magnetic resonance imaging (fMRI) is a useful method of monitoring 
cerebral activity during resting or task orientated activity or physiological stimuli. 
Chiefly, fMRI utilises Blood Oxygen Level Dependant contrast (BOLD) to 
anatomically resolve activity within the brain. The BOLD contrast method was 
developed by Ogawa et al, and has been adopted as a mainstream method of mapping 
cortical activity and cerebral function
14
. The basic principles allowing data from BOLD 
to be interpreted as cerebral tissue function is the absolute dependence on neuronal 
tissue to receive metabolic substrates from the blood as their only means of energy 
acquisition. Changes in tissue activity are therefore directly proportional to changes in 
blood flow. The technique is able to resolve the relative proportions of oxygenated and 
deoxygenated haemoglobin by the differing attraction the two substances experience 
within a magnetic field. Therefore areas of tissue containing differing ratios of 
oxygenated and deoxygenated can be resolved successfully using this modality. As 
NIRS-based parameters detect relative proportions of oxygenated and deoxygenated 
haemoglobin, the use of BOLD contrast signal as a yardstick for the validation of NIRS 
devices represents an attractive proposition
15
. As the BOLD signal is indicative of a 
relative change, values for absolute metabolic delivery and demand are not derivable, 
only the magnitude and timing of changes can be compared with NIRS parameters. 
Therefore validation and comparison of absolute quantitative baseline parameters 
cannot be undertaken in this investigation.  
A number of experimental and research based NIRS concepts including Diffuse Optical 
Tomography (DOT), and Diffuse Correlation Spectroscopy (DCS) have demonstrated 
considerable advancement in recovering parameters accurately reflecting cerebral 
oxidative activity and blood flow
16,17
 The advantage of these (particularly the recently 
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developed high density arrays) is the large number of sources and detectors improving 
special resolution and reducing the effect of superficial tissue vascular activity on output 
parameters. These have been shown to provide a comparable picture of cortical activity 
in recent investigations juxtaposing recovered parameters with contemporaneous 
fMRI
18, 19 
(with a lower level of topographical resolution). This indicates clearly that 
NIRS-based technology has the ability to reflect cortical vascular activity, however the 
complexity of the array and meticulous preparation involved make the DOT method of 
imaging impractical in the acute clinical setting. Simpler, easy to apply commercially 
available NIRS devices have been available for use in the clinical environment for a 
number of decades
20
. As stated previously, a principle concern over the use of these 
‘point of care’ NIRS devices to monitor cerebral tissue within an acute clinical context 
is the variable baseline readings, the validity of the changes detected, and concerns over 
the contamination of output parameters by activity in the superficial tissues
21
. The very 
nature of NIRS measurements mandates that light passing through cerebral tissue must 
always pass through the skin and extra cranial structures; therefore in all practical 
applications the activity within these tissues will always have some contaminating effect 
on the ‘true’ brain signal22. The most perfectly designed clinically applicable NIRS 
device would observe only activity from the brain parenchymal tissue (fig. 3), however 
this ideal set of circumstances has not yet been achieved.  
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Figure 5.3. Requirements of a perfect NIRS system 
Currently within the context of TBI the earliest opportunity to specifically optimise 
brain physiology, administer effective brain directed resuscitation or make decisions 
regarding specific surgical management is after admission to a hospital (or enhanced 
care setting) where brain imaging techniques or invasive brain monitoring is available. 
Hours may pass after injury before any specific knowledge regarding the exact nature of 
any brain injury, or state of brain health is established even after the arrival of out-of-
hospital clinicians. There is therefore a clear need to bring the monitoring of brain tissue 
outside of the tertiary care environment and earlier into the TBI patient journey. 
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5.2 Aims 
It is our aim to assess the correlation of the observations made by a commercially 
available, point of care cerebral NIRS device with those yielded by functional Magnetic 
Resonance Imaging (fMRI- Blood Oxygen Dependant Load signal BOLD) of brain 
activity during specific respiratory manoeuvres designed to provoke a marked change in 
cerebral physiology, specifically voluntary hyperventilation and the Valsalva 
Manoeuvre.  
Primarily we intend to investigate if the tissue activity as indicated by clinically viable 
(and commercially available) cerebral NIRS technology representative of observed by 
cerebral fMRI during these physiological manoeuvres. We also intend to investigate if a 
clinically available NIRS has similar abilities to fMRI in differentiating superficial 
tissue activity during these physiological stimuli.   
We anticipate that during a maximum effort Valsalva changes in tissue perfusion 
activity will differ between the extra cranial tissue and the brain, therefore this 
secondary question serves to demonstrate that when a NIRS device is placed on the 
forehead (a common clinical placement site) of an individual participant that the output 
parameters are chiefly brain derived and not overly influenced by input from the 
superficial tissues (to a degree that output parameters are invalid). Unfortunately MRI 
compatibility of the available hardware does not allow contemporaneous acquisition of 
NIRS based parameters during fMRI imaging. Potential translatability of our findings 
will be maximised by addressing these questions within a clinically relevant model, we 
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believe the significant shifts in physiology as provoked by a Valsalva manoeuvre 
provide this.  
5.3 Materials and Methods 
5.3.1 Design 
A prospective healthy volunteer study, conducted under controlled laboratory 
conditions. As highlighted above, equipment compatibility did not permit 
contemporaneous NIRS and fMRI observation. Therefore the test protocol was executed 
separately with each modality under similar conditions, but temporally distinct.  
5.3.2 Participants 
Nine healthy individuals recruited from within the university took part in this study after 
providing their informed written consent. The study conformed to the Declaration of 
Helsinki and was approved by the University of Birmingham Research Ethics Board 
(Ref.: ERN_30-1031). Volunteers recruited had no significant prior medical history. 
5.3.3 Procedure 
Voluntary hyperventilation and the Valsalva manoeuvre were specifically selected to 
elicit frank physiological responses similar in nature to those that occur during moderate 
or severe injury (marked reduction in perfusion or saturation of cerebral tissue). The 
nature and predictability of these effects make these suitable methods by which to test 
the ability of this NIRS device to detect changes in cerebral physiology and compare the 
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observations made with fMRI. Individuals performed a protocol that incorporated these 
manoeuvres while under observation by both NIRS and fMRI (Fig.5) 
Due to equipment restraints contemporaneous NIRS and fMRI testing was not possible, 
therefore separate identical clinical protocols were performed on each individual. In 
both cases the protocol was performed supine, with the adequacy and duration of 
hyperventilation and Valsalva monitored via end-tidal carbon dioxide partial pressure 
measurement (PetCO2), finger photoplethysmography (Portapres, Finapres Medical 
Systems, The Netherlands) allowing accurate real-time monitoring of blood pressure 
was utilised during NIRS measurements. This allowed optimisation of the Valsalva as 
individuals were requested to perform a maximal effort manoeuvre, with the blood 
pressure response to the manoeuvre utilised to ensure consistency. We aimed to induce 
the classical 4 phase response to the VM
23
, and both the presence of this and a 
consistent magnitude of response enabled us to ensure consistency.   
During voluntary hyperventilation individuals were directed (in terms of the frequency 
of their respiration) to maintain a consistent reduction in PetCO2 throughout each 
experiment, this allowed comparability to the effects between individuals (undertaken 
using a modified non-return face mask and respiratory gas probe). Following baseline 
measures, participants completed two 1-min bouts of hyperventilation that were 
separated by 1 min of rest (see fig 5). With both NIRS and fMRI testing both the 
Valsalva and hyperventilation protocol were performed immediately after one another, 
with the Valsalva being performed first in all cases as if hyperventilation preceded then 
a period of rest would have been required to ensure baseline PetCO2 levels were 
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restored (as post hyperventilation hypocapnia could significantly influence the Valsalva 
response
24
).    
 
Figure 5.4. Hyperventilation and Valsalva Protocol 
Event logging was undertaken, and synchronised between modalities. This protocol is 
not dissimilar to those previously employed in the literature demonstrating that the 
changes in physiology induced are detectable by NIRS devices
25-28
. Specific instruction 
and training was provided to ensure the Valsalva was completed in the MR scanner 
without undue movement artefact.  
For placement of the NIRS probes for the acquisition of brain derived data the same 
location on the forehead surface was selected in all participants. Right and left probes 
were placed 3cm above the superior orbital ridge on the forehead (below the hairline), 
with the lateral border of the pads approximately 5mm medial to the superior temporal 
line (to minimise muscle activity interference). This equated to a NIRS field of 
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acquisition approximately incorporating the middle frontal Gyrus (Brodman area 10) as 
per the fMRI region of interest, as localised via the Oxford-Harvard anatomical altas.    
In order for NIRS parameters to recover data from extra-cranial tissue during testing, 
the protocol was repeated with probes directed at a specific site on the facial skeleton 
(Fig. 6). As this device was being used in an ‘as purchased’ form, source detector 
distances where not modified and post hoc manipulation of the raw device output data 
was not undertaken. In order to optimise NIRS probe placement to capture data from 
somatic tissue (avoiding contamination from neurological tissue or disruption from air 
cavities/sinuses) probe placement was guided by pre-investigation library imaging (T1 
MR structural). Optimum probe location was selected along the line of the zygomatic 
arch, incorporating only skin, zygomatic bone and pterygoid muscle tissue within a 
2.5cm depth (beyond target depth of the device). Ideally parameters would be recovered 
from the superficial tissue overlying the forehead (identical location to the site of brain 
signal acquisition), however without modification superficial tissue signal cannot 
reliably be isolated with this device. Physiologically the difference in location suggested 
for superficial tissue signal acquisition should make no significant difference to the 
results seen, as they are not only within close proximity but supplied by identical 
sources and have similar neuronal innervation. For the purposes of fMRI analysis a 
region of interest was specified over the scalp surface corresponding to the brain tissue 
targeted NIRS probe location. With this approach we assessed whether haemodynamic 
activity within the brain and scalp tissue differed, and whether the parameters detected 
by our NIRS device during the NIRS session were reflective of brain tissue.    
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Figure 5.5. Placement of NIRS probes for brain and non-brain (somatic tissue) examination 
For the purposes of this investigation is was decided that tissue saturation (relative ratio 
of oxygenated/deoxygenated Hb) would be utilised as a sole NIRS parameter, as direct 
quantitative comparisons for each chromophore are not possible with the fMRI data. 
Saturation also potentially better reflects the changes observed by BOLD sequence 
imaging and is directly influenced by both Hb chromophores.  
5.3.4 Equipment 
NIRS Acquisition  
A frequency domain NIRS (FD NIRS) device (OptiplexTS™, ISS Inc. Illinois USA) 
was used to obtain our NIRS-based parameters. In standard clinically available form, 
this device utilises a single NIR light detector with 4 individual sources at 30, 35, 40 
and 45mm distances (each emitting the 2 device standard wavelengths of 680 and 
830nm). This configuration broadly allows for parameters to be recovered (at useful 
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resolution) from approximately 22.5mm below the surface (target depth).  A principle 
advantage of FD NIRS over more conventional continuous wave NIRS devices (utilised 
in the vast majority of clinical trials) is that values for light scatter within the tissues are 
not simply assumed. The intensity of the emitted light is modulated, allowing for 
absolute values of scatter to be determined via the observed phase shift in light at the 
detector (Fig. 4).   
 
Figure 5.6. fdNIRS concept 
MRI Acquisition 
A Phillips Achiva 3T (advantageous as sensitivity to BOLD contrast increases with the 
square of field strength) MRI scanner was used to acquire fMR data. Following basic 
structural T1 images, a single shot EPI sequence using a 32 channel coil was obtained 
during both voluntary hyperventilation and the Valsalva manoeuvre. For each sequence 
a 3x3x3mm voxel size was employed with no slice gap (ascending acquisition). The flip 
angle in this sequence was 80 degrees with an echo time of 30ms and a repetition time 
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of 2ms. Separate sequences were acquired for each physiological manoeuvre, with 
instructions relayed to participants via a customised (Matlab code based) visual 
feedback system. After normalisation into standard Talairach space the single voxel 
region of interest was positioned in each case over the white/grey matter junction of the 
middle frontal gyrus (brodman area 10) bilaterally with output data from each side 
combined into a single data stream (utilising the structural T1 images). Extra cranial 
BOLD signal was derived by free hand placement of each voxel into an area of facial 
somatic tissue corresponding with the field of acquisition of the NIRS probes at their 
point of placement (described below); as above a bilateral average formulated a single 
output data stream. Care was taken to place the region of interest within vascular 
hypodermal tissue, avoiding frankly avascular structures such as cortical bone, fat or the 
superficial dermis.  
5.3.5 Analysis 
BOLD data (AU) acquired from each specified ROI at a rate of 1Hz and was matched 
contemporaneously with NIRS data (saturation %) acquired at the same frequency.  
Analysis of the net change in parameters during Valsalva was analysed utilising the 
Wilcoxon rank sum method with multiple pairwise comparisons between the brain and 
ECT signals for both modalities. Time series and cross correlative statistical analysis 
was also undertaken.  
Broadly speaking, our pre-test physiological predictions were that the general trend in 
change during hyperventilation would be similar in both the brain and ECT. Due to this 
it was not expected that this manoeuvre would not serve as the theoretical separator of 
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tissue activity that the Valsalva would, in that the morphology of brain and ECT 
responses would broadly match. We therefore decided to focus statistical analysis on 
brain derived parameters and inter-parameter cross correlation/time series only, along 
with the likelihood that the data derived by both modalities is the same.    
To obtain this normalisation of the output data was undertaken where the initial value 
(at 1 second) was subtracted from all values and then scaled these by the largest 
absolute value. This was repeated for each patient so that all scaled values lie in the 
range -1 to 1.  The data was then modelled in terms of distribution and scaled values 
over time for each group using mixed models incorporating non-linear spline functions 
for the effect of time. The Welch–Satterthwaite equation was then employed to 
investigate baseline pooled variance (prior to Valsalva), this confirmed that at this time 
no difference in scaled values (all data normalised) between the NIRS and fMRI values 
from both brain and ECT. The explanation of this is potentially superfluous as this 
baseline modelling and standardisation of the data is a requirement for the appropriate 
analysis of time series (non-parametric) data such as this, but has been included for 
completeness.  The Kolmogorov-Smirnov test (two sample) was then employed to 
analyse the temporally based changes (during Valsalva) as two continuous one 
dimensional data streams (Brain and ECT). This test is primarily used to determine if 
continuous streams of data are likely to originate from the same source. 
Further to this we also examined the cross-correlation (CCF) of the two univariate 
samples; this allows the derivation of any potential data lag. From ‘causality’ between 
modalities can be assessed using a Granger test (this essentially examines two samples 
comparing how well the values of one are predicted based only on its own past values; 
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e.g. if NIRS parameters at time t is known then what does that tell us about 
simultaneous fMR parameters incorporating the derived value for lag). 
5.4 Results 
Nine individuals (6m, age 21-40) completed the prescribed protocol without 
complication.   
5.4.1 Valsalva Manoeuvre  
In all cases a satisfactory consistency in both the effort and timing of Valsalva was 
achieved. During the manoeuvre, both fMRI and NIRS output parameters showed a 
decrease in saturation for brain targeted approaches, while ECT targeted approaches 
showed an increase. Specifically, prefrontal NIRS saturation decreased by 7.2% (S.D 
4.77%) and fMRI decreased by 3.4% (S.D 1.46%), whereas ECT NIRS increased by 
6.1% (S.D 2.72%) and fMRI increased by 4.4% (S.D 3.45%).   These brain and ECT 
signals were found to be significantly different in both fMRI and NIRS (p=0.00025 and 
0.00115 respectively), with no significant difference between observations made by 
either device (P=0.22) between monitoring modalities. This demonstrated the ability of 
both techniques in this instance to differentiate brain from ECT during shifts in intra 
cranial physiology. 
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Figure 5.7. fMR / BOLD response to stimulus 
Visual inspection indicated that these both modalities track each other reasonably well 
(Fig. 8). Kolmogorov-Smirnov analysis demonstrated that the bilateral Brain derived 
NIRS parameters and fMR BOLD data from the bilateral middle frontal gyrus (MFG) 
unlikely to be from different sources (p=0.275).  
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Figure 5.8. Valsalva NIRS vs fMR BOLD Brain derived signal 
We found that the greatest CCF between modalities of 0.613 occurs when the fMRI 
BOLD Brain values are lagged by 0.5 seconds. Granger analysis based on the value for 
data lag derived suggests that NIRS brain values are associated with fMRI BOLD Brain 
values (P=0.52). 
Similar analysis was then undertaken of the ECT parameters recovered from both NIRS 
and fMRI during the Valsalva. Once again on visual inspection of the data demonstrated 
that each modality broadly tracks the other reasonably well (Fig. 9), although the 
specific morphology of the wave does not appear to have the same degree of conformity 
to the brain derived data.  Interestingly on applying the Kolmogorov-Smirnov test on 
these data we obtain a p-value of <0.001, suggesting that we have strong evidence in the 
data to indicate that these samples come from different distributions. This modelling 
and testing of the data suggests that NIRS Extra Cranial Somatic values are not 
associated with fMRI extra cranial Somatic values. However, after ascertaining that the 
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greatest CCF occurs at 5 seconds (lag) and applying this to the Granger model with a 
switched direction of causality  suggests that NIRS brain values are associated (strong 
cross correlation) with fMRI BOLD Brain values (p=0.5).  
 
Figure 5.9. Valsalva NIRS vs fMR BOLD ECT derived signal 
5.4.2 Hyperventilation 
A variety between individuals in the partial pressure of PetCO2 achieved during 
hyperventilation was observed (11mmHg to 22mmHg), potentially reflecting the 
differences in ability of each participant to breath in and out rapidly. Despite this 
variation each individual was able to reproduce a satisfactory degree of hyperventilation 
during both NIRS and fMRI testing. 
Again for the purposes of initial visual inspection the time series data from each 
individual patient was normalised respectively, and from this a reasonable visual 
agreement in time based activity was established (fig. 10) 
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Figure 5.10. Hyperventilation NIRS vs fMR BOLD Brain derived signal 
After initial data normalisation and modelling (as previously discussed), analysis of the 
data (again via Kolmogorov-Smirnov) produces a p-value of <1x10-7, suggesting that 
(as with the ECT Valsalva derived comparison) the data from these samples is highly 
likely to have been derived from different sources. However on examining the CCF of 
these two univariate samples we found that the greatest CCF (0.707) occurs at a lag of 0 
seconds. This modelling and testing of the data indicates that NIRS Brain 
hyperventilation and fMRI BOLD front values  exhibit some moderate cross-correlation 
(Granger analysis not required at 0s lag). 
5.5 Discussion 
The purpose of this study was establish if a readily available and clinically usable FD 
NIRS device is comparable to fMRI in its abilities to monitor significant haemodynamic 
changes in the brain in a physiological model translatable to TBI. Franceschini et al
29
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used a version of this device to obtain reflective quantitative values for oxygenated and 
deoxygenated Hb (utilising 8 emission wavelengths instead of the standard 2) from a 
group of healthy neonates. This modification afforded a greater degree of redundancy as 
more measurements reduce the overall impact of any single erroneous reading. A key 
facet of our investigation was to investigate the abilities of this device in its unmodified 
‘as purchased’ state (2 wavelengths only), as it is in this configuration that the device is 
currently available to clinicians and clinical scientists alike.    
This investigation has clearly demonstrated that both the FD NIRS device tested and 
fMRI have similar abilities in monitoring changes in cerebral physiology and 
differentiating activity between changes in brain physiological activity from concurrent 
activity in the tissues overlying the brain in our selected protocol. The data highlighting 
that both modalities (intra-cranially) are likely to be deriving their data from similar 
sources with good correlation between parameters during Valsalva, and a robust cross 
correlation was demonstrated in all our comparisons. However in the majority of 
instances our analysis highlighted that the origin of the data compared (between 
modalities) was unlikely to be from the same origin despite their good respective 
predictive values.  There are a number of possible explanations for this, notably that the 
extra-cranially derived parameters from NIRS and fMRI were not derived 
contemporaneously or from anatomically identical tissue (fig. 6). There is however 
possibly a more general reason, in that the compared streams of data are fundamentally 
different measurements (using different measurement methods entirely), although 
observing a similar a phenomenon (the binding of oxygen to haemoglobin).  
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As previously discussed the relevance of the Valsalva manoeuvre to the clinical 
application of these findings is important. The Valsalva provides a suitable validation 
model for a sudden reduction of cerebral perfusion accompanied by a simultaneous 
increase in intra cranial pressure, whilst simultaneously provoking a markedly different 
net effect in overlying tissues
30
.  
Demonstrating the ability of any surface applied non-invasive device (particularly 
NIRS) to clearly identify the distinctive pattern of activity exhibited by the brain tissue 
is an important exercise in testing such modalities for specific use within the context of 
TBI. An investigation in 2013 by Tsubaki et al
25
 utilised the Valsalva to highlight how 
significant changes in blood pressure effect NIRS output parameters in both the brain 
and overlying superficial tissues, and demonstrated that the Valsalva provoked a change 
in the relative baseline parameters from each (a change in the difference between the 
two at baseline). An important observation from our study is that a Valsalva causes an 
almost polar opposite NIRS parameter signature in each tissue, and therefore 
demonstrates the potential usefulness of this manoeuvre as tool to isolate a cerebral 
tissue signature. The use of a maximal effort Valsalva as oppose to a specific forced 
expiratory opposition pressure
26,29
 will have potentially contributed to the identification 
of this.  
The use of NIRS to monitor changes due to hyperventilation has been reported
31
; 
however the use of a comparative gold standard was not employed. From our own 
observations we cannot conclude that this particular manoeuvre has any special utility 
as a validator of NIRS parameters for use within the context of TBI. This is primarily 
due to the similarity in activity seen in both tissues during testing. The results however 
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are encouraging in terms of demonstrating that the changes observed by this NIRS 
device and fMRI have good visual agreement and acceptable cross correlation; 
supporting again the concept of the NIRS device being interchangeable with fMRI in 
terms of measuring relative changes in cortical activity.               
Investigations into the isolation of task based cerebral activity from that of superficial 
extra cranial tissue by waveform analysis have previously described how the increased 
water content and architecture of the later contributes to the reduced BOLD signal 
observed
32
. In order to minimise these effect Tachtsidis et al ensured placement of the 
BOLD acquisition voxel within the vascular hypodermis of the skin overlying cortical 
tissue. These observations were incorporated into our MR acquisition planning; 
however we still observed a significantly higher signal to noise ratio within our extra-
cranial fMRI measurements (S.D of change 3.45% vs. 1.46% within the group for 
cerebral and extra-cranial respectively). Other investigations by Tachtsidis et al
33
 have 
utilised wavelet coherence analysis in order to isolate superficial tissue signal 
component within NIRS output parameters. These provide promising potential for 
clinically applicable NIRS devices less susceptible to extra cranial contamination, 
however our experiment potentially suggests that noise reduction may not be as 
important in clinical situations where the magnitudes of changes such as those induced 
by a maximal effort Valsalva (translatable potentially to moderate to severe TBI with 
significant cerebral hypo-perfusion). We can deduce this by the ability of this NIRS 
device to differentiate clearly between the cerebral and extra cranial tissue signals.     
Investigations within the literature exist utilising further advanced/modified but similar 
FD NIRS hardware. Franceschini et al
29
 used a version of this device to obtain accurate 
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absolute quantitative values for oxygenated and deoxygenated Hb (utilising 8 emission 
wavelengths instead of the standard 2) from a group of healthy neonates. This 
modification afforded a greater degree of system redundancy. A key facet of our 
investigation was to investigate the abilities of this device in its unmodified ‘as 
purchased’ state (2 wavelengths only), as it is in this configuration that the device is 
currently available to clinicians and clinical scientists alike.    
Previous descriptions of the abilities of FD NIRS devices being compared to fMRI in 
monitoring changes in cortical activity have often concentrated on matching temporal 
and topographical changes in cortical surface activity (whilst considering the effect of 
surface tissue activity on parameters) during specific motor tasks
22
.  An important 
difference in our approach is the focus on the morphology of response (nature and 
magnitude in a single area/voxel) as oppose to topographical changes over the image 
defined cortical surface in previous investigations
18, 19, 22
. Conceivably observations 
based on the morphology and nature of the brains physiological response is more 
pertinent to the TBI clinical context. Here information regarding distribution of cortical 
function may be less useful then data indicating gross physiological changes which 
could be used as a tool to guide resuscitation. 
This investigation does not demonstrate that clinically viable (point of care) NIRS 
device (that utilise FD technology) have overcome all the limitations that have thus far 
prevented their widespread uptake into mainstream TBI care.  It does however 
demonstrate that these devices are clearly identifying brain specific physiology within 
this physiological context. This may be compromised with sub-optimal clinical 
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conditions (movement artefact, skin contamination and ambient light contamination), 
but none the less these results are encouraging.  
As discussed the concept of FD devices is to provide a more accurate quantitative 
assessment of the chromophore content of a given target tissue. Since trends were the 
main point of interest within this investigation, we have not directly evaluated any of 
these potential advantages. We must also consider the fact that that a comparison was 
not made directly with a traditional continuous wave device with similar system 
architecture (source detector spacing, subtraction algorithm) and therefore it may be 
difficult to derive any direct advantage of this technology from our results. Despite that, 
positive deductions can be made from our findings. 
Proportionately we witnessed a greater shift from baseline parameters during Valsalva 
from NIRS. This could have multiple explanations including modality specific noise; it 
may however indicate a greater level of contrast obtainable from NIRS derived imaging. 
In the majority of cases we demonstrated a lag between each data stream, with changes 
observed by NIRS prior to its recording by fMRI. This is highly likely to be related to 
the frequency of data acquisition (framerate), which is considerable higher (1hz vs 
0.33hz) in the NIRS device.  
5.6 Conclusion 
Output parameters produced by a clinically viable FD cerebral NIRS device are 
comparable with fMRI in its ability to resolve haemodynamic activity originating from 
the brain surface.  Data obtained from both modalities during a series of physiological 
manoeuvres in healthy individuals correlated robustly.     
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CHAPTER 6:  FREQUENCY-DOMAIN VS 
CONTINUOUS-WAVE NEAR-INFRARED 
SPECTROSCOPY DEVICES: A COMPARISON OF 
CLINICALLY VIABLE MONITORS IN CONTROLLED 
HYPOXIA 
Hypothesis 
That a point of care commercially available near infra red spectroscopy device 
benefitting from frequency domain parameter recovery has demonstrable benefits in 
clinically relevant situations (severe hypoxia) over the popular mainstream continuous 
wave devices.  
Abstract  
Background: The Near-Infrared Spectroscopy (NIRS) has not been adopted as a 
mainstream monitoring modality in acute neurosurgical care due to concerns about its 
reliability and consistency. However, improvements in NIRS parameter recovery 
techniques are now available that may improve the quantitative accuracy of NIRS for 
this clinical context. Aims:  to compare the abilities of a continuous-wave (CW) NIRS 
device with a similarly clinically viable NIRS device utilising a frequency-domain (FD) 
parameter recovery technique in detecting changes in cerebral tissue saturation during 
stepwise increases of experimentally induced hypoxia. Methods: Nine healthy 
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individuals (6M/3F) underwent a dynamic end-tidal forced manipulation of their 
expiratory gases to induce a stepwise induced hypoxia. The minimum end-tidal oxygen 
partial pressure (ETO2) achieved was 40 mm Hg. Simultaneous neurological and extra-
cranial tissue NIRS reading were obtained during this protocol by both tested devices. 
Results: Both devices detected significant changes in cerebral tissue saturation during 
the induction of hypoxia (CW: 9.8 ± 2.3%; FD: 7.0 ± 3.4%; Wilcoxon signed rank test 
P<0.01 for both devices). No significant difference was observed between the saturation 
changes observed by either device (P=0.625). An observably greater degree of noise 
was noticed in parameters recovered by the FD device, and both demonstrated equally 
variable baseline readings (Coefficient of variance 8.4 and 9.7% for the CW and FD 
devices, respectively) between individuals tested. Conclusion: No advantageous 
difference was observed in parameters recovered from the FD device compared with 
those detected by CW.  
6.1 Background  
Near-Infrared spectroscopy (NIRS) represents a brain monitoring modality with many 
inherent advantages over available alternatives, not least its non-invasive nature, ease of 
application and minimal inter-observer/operator variability. Although not yet considered 
sufficiently accurate or consistent in its observations to be utilised within the context of 
brain injury or acute neurosurgical care
1, 2
, the technology is commonly used in other 
clinical contexts that have potential implications on brain perfusion (e.g., cardiac 
surgery).  
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Since its introduction as a clinically available monitoring modality, considerable 
progress has been made in technology by which the NIRS parameters are recovered 
3, 4
, 
with parameter recovery techniques evolving from those dependant solely on 
continuously emitted light (continuous-wave) to those incorporating frequency 
modulation (frequency-domain) and time of flight data (time-domain). Continuous- 
wave (CW) devices rely on specific assumptions within an algorithmic reconstruction, a 
modified Beer-Lambert principle (Fig.1), based on the function of wavelength only 
regarding light scattering through the tissue medium containing chromophores (light 
absorbing substances). These basic principles critically assume that the degree of scatter 
within all areas of the field of NIRS acquisition is not only homogenous but also fixed. 
These assumptions are critical in the calculation of the recovered NIRS parameters, as it 
has been clearly demonstrated that modification of the reconstruction algorithm can 
produce very different results from identical raw NIRS data
5
. In addition to the reliance 
on assumptions made on scatter, another critical shortcoming of the CW is the assumed 
differential path length (L), which represents the estimated distance travelled by the 
light. This estimate fundamentally limits the accuracy of any interpretation of the output 
parameters.  
 
Figure 6.1. Modified and unmodified beer lambers concept 
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One reason for the vast majority of clinical investigations employing CW-NIRS at the 
point of patient care is the significant cost benefit over more advanced commercially 
available methods of NIRS parameter recovery
6
. In order to improve the validity of 
CW-NIRS, multiple algorithmic manipulations have been attempted to accurately 
resolve NIRS parameters from a specific depth and therefore isolate light that has 
followed a specific path through the biological tissue. These resolution techniques or 
spatially resolved spectroscopy (SRS) have been adopted widely to enhance the output 
parameters of multiple CW-NIRS devices, most notably the Suzuki SRS concept
7
 as 
implemented by Hamamatsu in their NIRO device. Although by no means the only SRS 
methodology, it serves as an excellent illustration of how parameters can be 
manipulated to improve the depth resolution of raw data obtained from CW devices.  
Briefly, this SRS analytical solution assumes that the plate of tissue is a semi-infinite 
space in either direction and incorporates the horizontal distance between the light 
source, the light detector (ρ) and the attenuation of the light received at the detector (A). 
In a NIRS array where a single source of light arrives at 2 separate detectors (each a 
specific distance from the source; e.g., 38 and 42 mm) the gradient derived from the 
difference in attenuation arriving at each detector and the distance between each 
detector (δA/δρ) is utilised in order to isolate the specific portion of the light detected 
that has passed through tissue of the specified depth (dependent on the source detector 
separation (Fig.2)).  
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Figure 6.2. Suzuki SRS concept 
Frequency-Domain (FD) NIRS is a progression of the CW concept that measures both 
light intensity attenuation and phase shift, since the intensity of the light emitted from 
these devices is modulated at a particular frequency. Specifically, observations 
regarding the shift in phase allow derivation of a more tissue specific value 
(quantification) of the degree of light scatter; hence the magnitude of this phenomenon 
is no longer assumed
8
. Theoretically, this enhanced technique allows more consistent 
quantitative measurements to be derived from biological tissue, particularly in the case 
of cerebral NIRS where a critical resolution of output parameters from a specific depth 
is required (Fig. 3).  
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Figure 6.3. Frequency domain concept 
Both of these techniques rely on a number of assumptions, and particularly in the case 
of CW devices (including those incorporating SRS parameter processing) this may 
contribute to superficial tissue perfusion adversely affecting the accuracy of these 
devices within the clinical arena
9
. Currently no clinical investigations exist to our 
knowledge quantifying the effect of superficial tissue blood flow on an FD NIRS 
device, although studies in healthy individuals have demonstrated this and made 
suggestions as to how to minimise its impact
10
. However even with its potential 
quantification of scatter within tissues this measurement is still en block (not depth 
specific) and will therefore be theoretically influenced by superficial tissue activity.  
The focus of this investigation is aimed at clinically viable devices, i.e., devices that are 
readily available, cost effective, usable by non-specialist staff, and have appropriate 
approval for use by the relevant regulatory bodies. Within the context of acute clinical 
care (particularly traumatic brain injury), any such monitoring tool should be easily 
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applied and removed with minimal preparation. Focusing our investigation on devices 
which meet these criteria maximises the translatability of any findings.  
Absolute changes in arterial partial pressure of oxygen (PaO2) and haemoglobin (Hb) 
saturation (SaO2) vary between individuals due to a variety of factors (e.g. variable 
compensatory reserves and baseline). Healthy individuals undergoing induced hypoxia 
(e.g. at high altitude or simulated high altitude) have been shown to vary in terms of 
their saturation and blood gas composition. Lucas et al
11
 demonstrated a PaO2 standard 
deviation of between 11mmHg (9.5% of total) at sea level and 3mmHg (7% of total) at 
high altitude (5050 m) with SaO2 demonstrating a standard deviation of 0.5% at sea 
level and approximately 3% at altitude. A similar distribution of variation was 
demonstrated in arterial partial pressure of carbon dioxide (PaCO2). We can infer from 
this that baseline variability (and standard deviation) in cerebral saturation at sea level 
and simulated altitude as observed by a NIRS device of sufficient quantitative accuracy 
to be utilised clinically should be within a similar order.  
6.2 Aims and study design  
In this study we aimed to simulate cerebral tissue hypoxia (a physiological change 
pertinent to Traumatic Brain Injury (TBI) pathology) in order to compare output 
parameters recorded simultaneously from clinically viable CW and FD cerebral NIRS 
devices. Our primary hypothesis being that the inherent advantages of a system that 
utilises frequency domain parameter recovery will demonstrate greater consistency, and 
accurate quantitative measurements then one without this technology.  
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We will test this by utilising a dynamic end-tidal forcing (DEF) system to induce 
stepwise hypoxia in healthy volunteers, looking to see if there are any significant 
differences in NIRS parameters observed simultaneously by each device, and if either 
NIRS modality measured changes in cerebral tissue with greater consistency (with 
individuals undergoing identical hypoxic insults). It is important to bear in mind that 
this investigation was not generally comparing the fundamental FD and CW parameter 
recovery techniques, instead we are comparing two clinically viable ‘point of care 
devices’ where one has the potential advantage of FD parameter recovery. There are a 
variety of differences within each device that represents a confounder to addressing that 
specific question (e.g. source detector configuration and specific algorithmic 
considerations).  
Each participant was exposed to isocapnic hypoxia using the technique of end-tidal 
forcing, which achieves accurate control of end-tidal gases by modifying the 
composition of inspired air on a breath-by-breath basis. This technique provides an 
intuitive model for studying all brain pathologies involving hypoxic changes. End-tidal 
carbon dioxide partial pressure (ETCO2) has been demonstrated to closely correlate 
with PaCO2
12
 and therefore, by fixing the end-tidal partial pressures during hypoxia we 
are also maintaining consistent PaO2 and PaCO2 and removing a confounding influence 
of ventilation on brain vascular activity. Although expensive and not widely available, 
this technique has proven effective in the research environment and has been used to 
demonstrate the significant influence of end-tidal carbon dioxide partial pressure has on 
brain blood flow and autoregulation
13
 during functional magnetic resonance (MR) 
imaging. We believe that these experimental conditions will narrow the variability of 
cerebral physiology driven by respiratory factors. 
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6.3 Methods  
6.3.1 Participants  
Healthy Volunteers recruited from within the University of Birmingham (UK) took part 
in this study after providing their informed written consent. The study conformed to the 
Declaration of Helsinki and was approved by the University of Birmingham Research 
Ethics Board (Ref.: ERN_30-1031). Individuals recruited had no significant prior 
medical history.  
6.3.2 Design  
A prospective healthy volunteer study, conducted under controlled laboratory 
conditions.  
6.3.3 Equipment  
The NIRO 200NX (Hamamatsu Photonics, Tokyo, Japan) CW spectrometer measuring 
at wavelengths of 735, 810, and 850nm was used simultaneously with an ISS 
OxiplexTS (ISS Inc, Champaign IL, USA) FD device measuring at wavelengths of 690 
and 830nm. Both these devices are portable, point of care devices that are commercially 
available to healthcare providers, and fulfill our requirements as clinically viable 
monitors. Their respective probes can be applied easily by individuals with minimal 
instruction and training. For ease of comparison and clinical translatability, a single 
output parameter from each device was selected. The Tissue Oxygen Index (TOI) and 
Tissue Hb Saturation were selected as parameters for comparison from the NIRO 
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200NX and ISS, respectively. It was felt that these represent popular clinically observed 
parameters, combining data from each Hb chromophore. Output parameters from each 
device were extracted at 1Hz for the purposes of direct comparison.  
To maintain continuous fixed end-tidal gaseous composition a custom made dynamic 
end-tidal forcing (DEF) device was employed. Gases were delivered and retrieved via a 
soft disposable plastic mouth piece via a filter. A nose peg was also applied to ensure no 
room air contamination due to inspiration through the nares.  
6.3.4 Procedure  
Individuals underwent a step-wise DEF induced hypoxia in a supine position on an 
examination bed tilted upwardly approximately 25 degrees. Simple skin cleansing and 
application of a device specific adhesive tape (in the case of the CW device only) was 
all that was undertaken in terms of surface preparation. Once the devices were in place, 
an elastic crepe bandage was then applied over the probes along with the addition of 
fabric tape to both secure the probes and minimise ambient light interference.  
Each device was assigned a fixed side of observation which was maintained through the 
experiment (CW right, FD left) and between all participants. One probe/channel was 
placed on the forehead with the probe centre point located 4cm from the midline and 
3.5cm above the superior orbital ridge (targeted at cerebral tissue) (Fig. 4). The second 
probe/channel of each device was placed over and in line with the zygomatic arch, 
targeted specifically at non-neurological (somatic tissue). The purpose of this placement 
was to observe any overt difference between cerebrally targeted and non- cerebrally 
targeted NIRS parameters during hypoxia, and if this varied between devices. This field 
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of NIRS acquisition in health incorporates skin, bone (posterior zygoma) and muscle 
(pterigoid and temporalis) but no air. Anatomically this region would not normally 
incorporate and air cavity, and this was confirmed on a number of participant specific 
archive MR images.  
 
Figure 6.4. NIRS position and DEF system 
An initial room air stabilisation period (ascertaining baseline expiratory gas 
composition) proceeded formal clamping of end-tidal gases to ensure participant 
comfort and consistent readings. From here, an initial end-tidal gas clamp was then 
applied, with end-tidal Oxygen and Carbon Dioxide clamped at 100mmHg and 
40mmHg respectively. This was maintained for 5 minutes before the commencement of 
2 stepwise 5-minute periods of hypoxia, with isocapnia maintained. The first 5- minute 
stage of hypoxia reduced an individuals inspired oxygen to a partial pressure of 
60mmHg, with the second reducing this further to 40mmHg. After this the baseline 
clamp values were then restored and maintained for the final 5 minutes of the protocol 
(Fig. 5). Participants were asked to relax and rest during the procedure, and to breathe as 
naturally as possible.  
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Figure 6.5. Isocapnic hypoxia protocol 
Participants were continuously monitored by qualified clinical staff during the 
procedure, and non-verbal contact was maintained during the procedure to maintain 
comfort and safety.  
6.3.5 Data Analysis  
Simultaneous data obtained from both NIRS devices during the hypoxia protocol from 
each individual was directly compared. A variety of parameters were compared, 
including: baseline noise, baseline mean values, the quantity of change observed during 
each phase of isocapnic hypoxia and the magnitude rebound re-saturation observed 
when the hypoxia clamp was released. Data was compared using a variety of descriptive 
statistics and paired non-parametric statistical tests including Wilcoxon signed rank test. 
All data analysis was carried out using in house written code in a commercial software 
package (MATLAB (R2015a) Mathworks Inc. Natick, Ma, 2000). 
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6.4 Results  
6.4.1 Baseline Variability and Noise  
A total of 9 healthy individuals (6 Male) completed the isocapnic hypoxia protocol. One 
participant was unable to tolerate the second stage (40mmHg) hypoxia for the full 
specified 5 minutes due to discomfort. The initial 100 seconds of this second stage of 
hypoxia was maintained and stable output parameters were observed, therefore this 
individual’s data was maintained for analysis.  
For practical purposes during our analysis the two stages of hypoxia will be considered 
as a single step change in observed parameters. The main reason for hypoxia being 
induced in 2 stages was largely one of participant comfort. The mean baseline 
parameters observed in the somatically targeted probes were consistently higher than 
parameters recorded by those targeted at brain tissue (77% vs 63% CW/NIRO and 
72.7% vs 61.8% FD/ISS; P=0.0078 and 0.0039, respectively). Consistently a greater 
level of noise was observed by the FD (ISS) NIRS device throughout the experiment 
(S.D of baseline traces 1.37 vs 0.87%). In terms of baseline variability, both devices 
demonstrated a marked variability in baseline parameters (Table 1).  
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 Baseline TOI (%)  
(mean ± CV) 
Hypoxia TOI (%)  
(mean ± CV) 
Post release TOI (%)  
(mean ± CV) 
NIRO Forehead 63.2 ± 8.4 53.4 ± 11.9 62.7 ± 11.1  
NIRO Zygoma 77.0 ± 10 68.3 ± 9.54 77.9 ± 10.2 
ISS Forehead 61.8 ± 9.7  54.8 ± 7.93 62.8 ± 9.9 
ISS Zygoma 72.7 ± 6.8  64.1 ± 5.26 72.4 ± 6.7 
 
Table 6.1. Table of baseline means and coefficients of variance (CV) Wilcoxon Rank test 
Significance 
6.4.2 Observed changes during hypoxic clamp  
The brain directed parameters (% Saturation/TOI) observed by both devices changed 
markedly on moving from the initial baseline clamp to the second stage of induced 
hypoxia (i.e., 9.8% and 7% reduction from baseline for the CW/NIRO and FD/ISS 
devices, S.D 2.3 and 3.4% respectively) these changes were statistically significant 
(Wilcoxon signed rank test p<0.01 for both devices). Similar significant changes were 
seen in the non-neurological somatically targeted probes (p<0.01 for both devices).  
The changes observed during hypoxia between the neurologically targeted probes and 
those targeted at the zygomatic/somatic tissue were not significantly different in either 
probe (p=0.1289 and 0.3594 NIRO and ISS respectively). This suggests a similar level 
of desaturation during hypoxia in both tissues, although caution must be taken in 
interoperating these results, this is a small sample size and a larger investigation may 
yield different results.  
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6.4.3 Observed cerebral changes during release from hypoxic clamp  
After release of the hypoxic clamp a substantial increase in cerebrally derived 
parameters was seen in both devices. This was the single largest change in parameters 
seen during the protocol. In both cases the changes seen by each device (from 40-
100mmHg) were highly significant (P=0.001953 for both the NIRO and ISS), indicating 
once again that both devices clearly demonstrate the ability to detect the changes 
induced by the release of the hypoxia clamp. In all cases stable post release (100mmHg) 
parameters were obtained within 40 seconds. A mean rise from hypoxia of 9.7% was 
detected by the NIRO (Range 4.4-13.4% median 13.2%), with the ISS observing a 
slightly lower average change of 8.9% (Range 4.6-13.7% median 9.6%). There was no 
statistically significant difference between the changes detected by either device 
(P=0.625).  
6.5 Discussion  
We have demonstrated that both of the devices tested have the ability to detect both the 
significant decrease in derived NIRS tissue saturation during induced hypoxia and the 
significant increase in these seen after release of the hypoxic clamp. Of interest was the 
performance of the ISS/FD device which seemed to perform in an indistinguishable way 
in its ‘as purchased’ form to the NIRO/CW device, despite the theoretical/technical 
advantage of its FD parameter recovery method. It is also noteworthy that the output 
parameters produced by this device were noticeably noisier (Fig. 6). This would 
potentially prove a disadvantage within the clinical arena and in particular acute 
traumatic brain injury (TBI) care, where observational conditions could be sub optimal.  
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Figure 6.6. Typical participant plot 
The consistently lower baseline parameters observed by the probes targeted at brain 
tissue (compared to those targeted at somatic tissues in the facial skeleton) could be 
explained physiologically by the significantly lower baseline oxygen demands of the 
resting state bone, muscle and skin tissue compared to the brain. This is an interesting 
observation, highlighting the very different nature of the tissue under the respective 
probes and reaffirming the ability of both devices to detect cerebral activity. A 
limitation of this investigation is that we have not identified the specific degree by 
which the superficial tissues have influenced these parameters in either device, and 
therefore these results are to be interpreted appropriately. The incorporation of different 
physiological changes (hypocapnia) or other respiratory manoeuvres may potentially 
help quantify this in future studies.  
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The level of noise observed in the output parameters of the ISS/FD device was 
noticeably (and consistently) greater than that seen from the NIRO/CW. This may be 
explained by the highly sensitive phase measurements made by this frequency- domain 
model, detecting moment- to- moment changes in physiology and as output data are at a 
modest 1Hz this would intuitively lead to a more noisy trace (Fig. 6). In addition the 
FD/ISS device utilised fibre optic light transfer which is then amplified within the 
device by a photo-multiplication device, as opposed to the NIRO/CW device which 
detects light from the tissues directly via surface photodiodes. These differences in light 
detection methods may also contribute to the levels of noise observed in output 
parameters.  
For the purposes of clinical application, the coefficient of variance of baseline cerebral 
parameters seen (8.4 and 9.7% for the NIRO and ISS respectively) is greater than the 
reduction seen in the case of 3 subjects in the case of the NIRO, and 4 subjects in the 
case of the ISS. This indicates that the baseline parameters obtained from either device 
is not sufficiently consistent to be utilised for clinical purposes.  
The outcomes of this investigation cannot be extrapolated to FD-NIRS technology in its 
entirety, but in this tested ‘point of care’ configuration. Franceschini et al14 reported 
accurate quantitative measurements in a cohort of healthy neonates. This utilised a 
modified ISS/FD device emitting an additional 4 wavelengths of light (6 vs 2) from 
each source diode, increasing system redundancy and providing clinically accurate 
output parameters. Due to these examples in the established literature we are cautious to 
apply our findings to FD-NIRS generally. Therefore, FD certainly has the potential to 
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enhance the clinical application of NIRS, despite no clear indication of an advantage in 
our findings.  
The focus of this investigation was on the ‘as supplied’ unmodified form of the devices, 
as modification of these devices requires specialist knowledge and is potentially not 
immediately translatable to clinical care. With this in mind, we found that in tested form 
our FD device did not demonstrate distinguishably different abilities from the CW 
NIRO 200NX.  
In terms of clinical application, both devices could potentially be utilised to observe 
changes in cerebral physiology, however baseline parameters (quantitative 
measurements at the commencement of observation) are highly variable and not useful 
for clinical decision-making. These limitations are widely acknowledged
15 - 17
 and the 
significant variability observed in studies contemporaneously comparing NIRS to 
functional MR imaging
18
. The obvious potential benefits of FD-NIRS were recognised 
by Charbel et al. in 2007
19
, when they undertook an investigation into to abilities of a 
device (similar to device employed by our investigation) to detect ischemic changes 
during vascular neurosurgical procedures. They reported satisfactory detection rates of 
ischemia. However, their methodology focused primarily on the relative changes to 
initial baseline (although making reference to absolute chromophore quantity).  
Both probes detected significant changes in parameters during the induction of hypoxia. 
This combined with the significantly higher baseline saturation seen in the somatic 
facial tissue indicates that both devices are capable of reliably detecting the change in 
specific cerebral oxygenation induced, and either one could be used as an effective 
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monitoring tool (within the tested context). The changes we observed were not 
unexpected as we anticipated a marked change in cerebral saturation after inducing such 
a profound hypoxia equivalent to what would be experienced at the summit of the 
world’s tallest mountains (5000 meters).  
Within the specific context of acute TBI care (particularly within a pre-hospital 
context), decisions regarding brain health and the need for intervention are often 
required soon after patient contact. Should NIRS be utilised in the clinical decision 
making process in this tested form little could be derived from the initially extracted 
parameters. Certainly a trend could be established as to the direction of change in 
parameters after a period of observation; however without initial validation/calibration 
(with invasive monitoring or axial imaging) this would not be useful in immediate 
management. When a baseline level of function/brain health is known (as in cardiac 
bypass surgery /cardiopulmonary resuscitation) the uncertainty regarding baseline 
parameters becomes less important and the change in trends observed becomes 
clinically useful
20, 21
. For any NIRS device to be employed suitably within a TBI 
context it must be able to clearly distinguish grossly abnormal parameters (such as those 
related to significant hypoxia) from the expected normal observations of the majority of 
individuals.  
Currently, true quantitatively accurate NIRS parameters have only been obtained within 
breast tissue
22
, utilising a diffuse optical tomographic (DOT) array. These techniques 
involve large (clinically impractical) arrays of sources and detectors and parameters are 
not able to be effectively reconstructed in real time, and still fail to provide absolute 
quantification in the context of cerebral tissue monitoring
23
. A significant limiting factor 
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in all currently available (clinically viable) NIRS devices is knowledge of spatial 
priors
24
 (specific dimensions of tissue layers), and incorporation of patient specific atlas 
(MRI) based data may aid in the development of future clinically viable devices that can 
provide a better quantitative measurement of chromophore concentration within 
cerebral tissue
25
.  
6.6 Conclusion  
Although FD-NIRS clearly has many advantages over continuous-wave devices, our 
investigation demonstrated that the device tested performed indistinguishably from a 
similar clinically available ‘as supplied to clinicians’ CW device within the context of 
detecting induced hypoxia. The variability seen in baseline parameters between 
individuals (in this limited investigation) by FD-NIRS is similar to that of CW devices, 
and therefore does not offer any direct advantage of CW devices in the acute assessment 
setting.  
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CHAPTER 7:  CEREBRAL OXYGENATION IN 
TRAUMATIC BRAIN INJURY; CAN A NON-INVASIVE 
FREQUENCY DOMAIN NEAR INFRARED 
SPECTROSCOPY DEVICE DETECT CHANGES IN 
BRAIN TISSUE OXYGEN TENSION AS WELL AS THE 
ESTABLISHED INVASIVE MONITOR? 
Hypothesis 
That a clinically viable point of care near infrared spectroscopy device has sufficient 
sensitivity in detecting cerebral hypoxia to replace invasive brain tissue oxygen tension 
measurement in severe trauamatic brain injury.  
Abstract 
Introduction: Traumatic brain injury is a major worldwide cause of morbidity and 
mortality, the invasive measurement of brain tissue oxygen tension is an integral part of 
multi-modal intra-cranial monitoring within this context. The cost and highly invasive 
nature of this monitoring modality currently restrict its utility to specialist neurological 
intensive care settings. An easily applied non-invasive equivalent would have a number 
of significant advantages over these techniques. Aims: To test the abilities of a non-
invasive point of care near infrared spectroscopy (NIRS) device benefiting from 
enhanced frequency domain (FD) parameter recovery technology in predicting changes 
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in invasively measured brain tissue oxygen tension.  Methods: Individuals admitted to a 
United Kingdom specialist major trauma centre were contemporaneously monitored 
with an FD NIRS device and invasively measured brain tissue oxygen tension probe. 
Area under the curve receiver operating characteristic (AUROC) statistic analysis was 
utilised to assess the predictive power of NIRS in detecting both moderate and severe 
hypoxia (20 and 10mmHg respectively). Results: 16 individuals were prospectively 
recruited to the investigation. Severe hypoxic episodes were detected in 9 of these 
individuals, with the NIRS demonstrating a broad range of predictive abilities (AUROC 
0.68-0.88) from relatively poor to good. Moderate hypoxic episodes were detected in 
seven individuals with similar predictive performance. Conclusion: A variable 
performance in the predictive powers of this FD NIRS device to detect changes in brain 
tissue oxygen was demonstrated. Currently this technology has not demonstrated 
sufficient ability to replace the established invasive measurement.   
7.1 Introduction 
Traumatic brain injury (TBI) is a significant global health problem constituting a 
significant and expanding disease burden, within the United States and other similar 
western economies it is thought to directly affect up to 2% of the population
1
. It is a 
broad spectrum of pathology, encompassing a variety of levels of severity from mild 
injury where recovery is brisk and complete to death or devastating injury resulting in 
the requirement for life long care.  
In the case of moderate to severe TBI (where consciousness is impaired and significant 
neurological damage has been sustained), invasive monitoring of various brain-based 
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physiological parameters is required. Output parameters from the multitude of 
monitoring modalities can then be utilised by clinicians to; 
- Optimise intra-cranial homeostasis (for brain tissue preservation) 
- Orchestrate timely surgical or non-surgical intervention 
- Forecast prognosis and formulate suitable management plans based on these. 
A number of essential, brain-specific modalities are utilised within this context to 
monitor moderate to severe TBI, all of which are invasive and are therefore associated 
with morbidity. These are used alongside general systemic physiological parameters 
such as arterial blood pressure, blood gas composition, core temperature and pupillary 
reflex function. The most frequently employed are intra-cranial pressure (ICP) 
measurement, brain tissue oxygen tension measurement (PbtO2), and cerebral tissue 
microdialysis
2
.  In the absence of contemporaneous operative intervention (craniotomy) 
all of these require an access hole to be drilled into the skull vault along with a wire or 
catheter to be passed through cerebral tissue. This constitutes an invasive procedure, 
with an associated potential morbidity
3
 and high equipment cost arising from single-use 
items.  
This method of ICP monitoring is the most commonly applied invasive monitoring 
technique in TBI. Despite this the evidence surrounding the intensive management of 
these patients, based directly on the absolute values of this parameter, is equivocal
4
, and 
potentially has no discernible benefits over serial axial/CT imaging; however this 
evidence must be considered carefully within the confines of the surgical equipoise on 
which they were executed.  
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Recently the invasive measurement of cerebral tissue oxygen tension (PbtO2) has 
become an established adjunct to the measurement of ICP
5
, and substantial evidence 
exists to suggest that making clinical decisions and guiding management based on this 
parameter have a positive effect on clinical outcome
6
. Beyond its current independent 
abilities, PbtO2 also has the advantage of providing more detailed information regarding 
changes in brain oxygenation and perfusion than pressure measurement alone, this in 
turn allows for qualification of metabolic data
7
. Despite these promising findings, 
PbtO2 still represents a highly invasive and expensive method of monitoring brain 
physiology after TBI, its use (like all similar modalities) is currently limited to critical 
care centres within tertiary referral (specialist) centres.  A non-invasive monitoring 
technology that can demonstrate an accurate reflection of this parameter and an 
acceptable equivalence would be extremely useful in expanding the effective 
monitoring of brain physiology earlier in the patient journey and beyond this specialist 
environment. The potential reduction in cost and potential morbidity would also be 
significant advantages of such a monitor.  
Near Infra-Red Spectroscopy (NIRS) represents a clinically viable method of 
monitoring brain physiology within a number of important clinical contexts
8
. 
Fundamentally this technology relies on the passage of Near infra-red (wavelength 700-
1000nm) light through a proscribed block of target tissue, the degree of absorbance of 
this light (as predicted by the Beer-Lambert principle. Fig. 1) is then directly 
proportional to the quantity of target absorbing molecules (chromophores: Chiefly 
oxygenated and deoxygenated haemoglobin) within the volume of tissue passed through 
by the emitted photons. This basic explanation relies heavily on the premise that 
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absorption is the most influential interaction of the light in question with the biological 
tissue, where in fact scatter is also a significant factor.   
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Figure 7.1. Original and Modified Beer-Lambert principle incorporating 
assumptions regarding scatter 
The mainstream utility of NIRS in TBI management has been limited due to a number 
of concerns regarding the reliability of output parameters within this setting to 
contribute to clinical decision making
9, 10
.  Many theoretical explanations regarding why 
the technology has failed to demonstrate sufficient accuracy (particularly within TBI) 
have been proposed. Signal contamination from superficial (non-brain) tissue, the 
inability to confidently quantify photon scatter within tissue, and the absence of 
absolute quantitative measurements of chromophores are considered among the most 
important factors for consideration
11
. The overwhelming majority of clinical 
investigations into the use of NIRS in TBI have utilised a traditional form of the 
technology (continuous wave parameter recovery) in which the amount and nature of 
tissue scatter are assumed, and homogenous through the observed tissue
9
. At the present 
time this technology has not yet demonstrated sufficient ability to replace invasively 
measured intra-cranial parameters including PbtO2 measurement
8-10
.  
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Within the context of TBI quantitatively accurate parameters and the reduction in inter 
subject variability that accompanies this are of particular importance. In many clinical 
settings where NIRS has demonstrated useful utility a key factor is prior functional 
knowledge of the patient specific functional (neurological) status
9
. Here the initial NIRS 
parameters are meaningless, and can be normalised to an arbitrary unit baseline, simple 
knowledge of how these parameters change over a period of observation is sufficiently 
useful. In TBI management quantification of the injury sustained (in comparison to 
normal physiology) is essential early in the patient journey. 
Many advances in NIRS technology have been implemented to overcome its limitations 
and facilitate its greater use in key clinical settings; of note is the development of 
frequency domain (FD NIRS) parameter recovery.  Continuous wave devices emit light 
into target tissue at a constant intensity, whereas FD NIRS continuously modulates this 
intensity. These changes in intensity are detected, allowing an assessment of phase shift 
(Fig. 2). From these a tissue specific value for light scatter can be derived and 
incorporated into the device output parameters, in turn this will theoretically improve 
their quantitative accuracy.  
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Figure 7.2. Illustration of the FD NIRS concept 
A number of important advances in NIRS parameter recovery demonstrating promising 
improvements in quantitative accuracy have involved complex skin contact arrays
11,12
, 
and expensive (often customised ) light emitting and detection technology
13,14
.  
However, this technology has (as yet) not been tested in the mainstream clinical TBI 
area as to its ability to replace mainstream invasive monitoring modalities or be utilised 
independently.  
7.2 Aims 
Our two primary aims are;  
1) To investigate the abilities of a commercially available and clinically viable FD 
NIRS device to predict clinically significant changes in contemporaneously 
measured brain tissue oxygen tension within the context of TBI patients.   
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2) To ascertain whether or not parameters recovered from this point of care FD NIRS 
device are sufficiently accurate and consistent to be used independently (for clinical 
decision making) in TBI patient care. 
7.3 Setting 
The University Hospital Birmingham, Queen Elizabeth represents one of the largest 
tertiary referral and major trauma centres in the UK. The neurosurgical and traumatic 
brain injury service serves a population of over 4 million individuals, it also represents 
the primary role 4 medical facility for the UK armed forces, with the headquarters of the 
Royal College of Defence medicine situated on site.  
7.4 Methods 
National and institutional ethical approval was obtained for this investigation as part of 
the National Institute for Health Research portfolio study Red Diamond (approval code 
14/EE/0165, July 2014). Due to the nature of the investigation, consent at the time of 
enrolment in all cases was obtained either by a nominated professional or personal 
consultee.  
7.4.1 Equipment  
The Raumedic PbtO2 invasive brain tissue oxygen measuring system is an established 
and commercially available monitoring system utilising fluorescence-quenching 
technology.  This detects changes in free oxygen concentration within a given medium 
via a reduction or ‘quenching’ of the fluorescence (to a specific wavelength of light) of 
150 
a given substance (in this specific case pyrene di-butyric acid
15
) by the presence of 
oxygen (Fig. 3). Alternatively available systems utilise a Clarke cell
16
 (Catalytic 
platinum electrode under a permeable membrane) to quantify free oxygen. Reports 
within the literature suggest that these two methods are at least equivalent in terms of 
their accuracy
17
, however the fluorescence quenching method has certain theoretical 
advantages including negating the requirement for a metallic catalyst within the tip of 
the electrode and a theoretical improved resistance to particulate fouling of the detection 
interface. Placement of the Raumedic PbtO2 catheter can be either via an intra-cranial 
bolt or tunnelled free-hand placement, the device is fully MRI compatible and is a 
combined ICP and brain tissue temperature sensor (removing the requirement for an 
additional ICP monitor). When introduced via the proprietary bolt system the depth of 
tissue penetration is fixed, in cases where this was utilised the manufacturers specific 
drill was utilised. The position and insertion method of each invasive monitor were 
recorded, in cases of where open surgery was not performed prior to the insertion of the 
monitor (and without any additional indication) the bolt was placed over knocker’s 
point  (right side, 2cm anterior  to coronal suture, mid pupillary line) in line with our 
ethical approval to follow standard departmental procedure.   
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Figure 7.3. The effect of oxygen on the florescence (photon energy transfer) 
of pyrene di-butyric acid 
The ISS (Il, USA) Optiplex TS is a commercially available and clinically viable point of 
care FD NIRS device. In standard form (as used) it has 2 functioning channels with a 
linear 4 source / 1 detector layout (fig. 4). Each source emits light at 2 wavelengths of 
680 and 830nm, this combined with its intensity modulation provides a (theoretical) 
quantitative output parameter (micrograms of chromophore within the region of 
acquisition) for both oxygenated and deoxygenated haemoglobin (Hb).  Flexible contact 
pads incorporate the source/detector array, with light transmitted to and from the skin 
via fibre optic bundles with detected light augmented via a photo-multiplication device 
(PMT).  
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Figure 7.4. ISS NIRS probe source / detector layout 
Both monitoring modalities were set at identical data acquisition frequencies of 1Hz, 
with synchronisation of data streams undertaken contemporaneously (Fig. 4); higher 
resolution observation was available but not undertaken. Event triggers on respective 
devices logged significant events.  
 
Figure 7.5. Illustration of in vivo data acquisition configuration 
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7.4.2 Procedure 
Eligible patients are identified through the institutional neurosurgical referral service by 
research staff. Consent was then obtained once it was established that invasive intra-
cranial monitoring was mandated.  
The ICP/PbtO2 catheter was placed as dictated by clinical requirement (bolt/tunnelled), 
including site/side of catheter. Fibre optic integrity was then confirmed along with an 
oxygenation challenge to confirm functionality of the probe as described by Wilensky et 
al
17
. Failure to establish a reliable and reactive tissue oxygen tension measurement 
excluded that individuals data from the primary analysis. Radiological investigation to 
confirm the anatomical site of the catheter tip was not routinely performed. 
Regular calibration of the ISS NIRS device was undertaken with manufacturer supplied 
(fixed scatter property) gel blocks to ensure consistent measurements throughout the 
investigation.  NIRS probes were placed symmetrically on both sides of the forehead, 
with prior surface preparation and cleaning of the skin. On each individual the centre of 
the probe (corresponding approximately to the field of NIRS acquisition) was placed 
approximately 2cm superior to the supra-orbital ridge in the mid-pupillary line. After 
establishing a stable baseline signal, the probes were secured and shielded from ambient 
light contamination with a 6cm wide elastic bandage, this also served to stabilise the 
associated fibre optic lines.  
Once stable simultaneous observations were established data markers were placed 
simultaneously on both modality loggers allowing accurate synchronisation of the data 
streams. Recording would then be continued for the duration of clinical monitoring or 
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up to 72 hours after injury (whichever occurred first). No more than 20 hours of 
continuous observation was undertaken to minimise the risk of skin necrosis due to the 
presence of the pads.    
7.4.3 Inclusion / Exclusion Criteria 
Inclusion criteria into this investigation included adult patients admitted with moderate 
or Severe TBI requiring the insertion of an invasive cerebral monitor. 
Specific exclusion criteria included; 
 Any significant frontal bone or soft tissue injury causing significant disruption of 
the normal anatomy 
 Existing frontal / bi-frontal craniectomy or bony defect under NIRS probe 
placement site (pre-monitoring) 
 Frontal extra/sub-dural haematoma or contusion within the field of NIRS 
acquisition.  
 Any pre-existing chronic or progressive neurodegenerative disease  
7.4.4 Data Acquisition and Analysis 
Continuous 1Hz data acquisition was acquired and recorded for both NIRS and PbtO2, 
for the purpose of analysis only NIRS data acquired from the channel ipsilateral to the 
inserted invasive monitoring catheter was considered (as this is acknowledged as a 
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local/focal measurement). For both modalities data was recorded via device specific 
loggers, and exported in excel format after protocol completion for analysis.  Output 
data relating to PbtO2 is recorded as an absolute partial pressure (mmHg), and NIRS 
parameters were recorded (for the purposes of analysis) as Hb saturation. This was felt 
to be the most appropriate NIRS based parameter as it incorporates data from both 
oxygenated and deoxygenated Hb.  
For the purposes of analysis the PbtO2 values were categorised in terms of significant 
change and absolute values as follows ; 
1) Severe hypoxia as a change in Pbt02 below 10mmHg  
2) Mild hypoxia as a change in Pbt02 below 20mmHg 
These numbers are based on a number of extensive published investigations quantifying 
physiological and pathological values PbtO2 within the context of TBI, with 
accompanying outcome data
5,6,17,18
. The identification of episodes of invasively detected 
ischemia by our selected NIRS device is a primary aim of this investigation, point 2 of 
our aims focuses on the abilities of this monitor to be used independently within the 
context of TBI. We therefore feel that NIRS technology should be sufficiently sensitive 
to detect moderate changes in PbtO2.  
These definitions were then used to conduct logistical regression analyses utilising Area 
Under Curve Receiver Operating Characteristics (AUROC) to relate changes in NIRS 
parameters (saturation) to changes in PbtO2. This method of analysis gives a measure of 
discrimination, quantifying the ability of any point measurement in NIRS saturation to 
predict hypoxia. The closer the AUROC value to 1 the better the discriminative ability. 
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An AUROC value of 0.5 is approximately equivalent to the average performance from 
guessing at random.   
7.5 Results 
A total of 16 patients (13m/3f) were recruited to the investigation between December 
2014 and March 2016. In 4 of these individual specific equipment issues (inadequately 
reactive PbtO2 trace, overly noisy NIRS parameters, evolving forehead haematoma) 
made useful analysis of the data impossible, they were therefore excluded.  
Of the 12 remaining recruited patients (9m/3f) the mean age of these individuals was 
50.5yrs (median 54, S.D 17.5yrs). The most frequent mechanism of injury sustained 
was fall (n=6), followed by road traffic collision (n=4), blunt object assault (n=1) 
gunshot injury (n=1). The mean initial (best) post-resuscitative GCS of these individuals 
was 8 (range 4-11, median 8, S.D 2.3), with the majority (n=7) sustaining a severe TBI 
as classified by an initial GCS of 8 or less.  
The mean time from injury to commencement of contemporaneous bi-modal monitoring 
(PbtO2 and NIRS) was 12.2 hours (median 12, S.D 5). A total of 1,021,590 paired data 
points were analysed (over 283 hours across all 12 patients), with 160,576 
measurements representing severe hypoxia, and 492,988 measurements representing 
moderate hypoxia. The smallest individual patient data stream was 16,200 (4.4 hours) 
data points, the largest 111,000 (30.5 hours) and a mean of 86,901 (24 hours) data 
points across the group.  
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In certain patients, corresponding data plots between NIRS and PBtO2 demonstrated 
good agreement on visual inspection (fig. 5), however in a number of cases this was not 
the case (fig. 6).  
 
Figure 7.6. Good visual agreement between modalities 
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Figure 7.7. Poorer visual agreement between modalities 
After initial inspection by institutional statisticians, and the construction of best-fit 
regretional model (flexible splines) a considerable variability in the change in NIRS 
parameters for a given change in brain tissue oxygen tension was observed (a significant 
change in NIRS parameters predicting hypoxia in one patient was very different from 
that recorded in another). The relationship was also non-linear, in that the change in 
NIRS saturation accompanying a change in PbtO2 varied depending on pre-event 
parameters. It was therefore considered impractical to consider the data set (all patients) 
as one continuous stream, and therefore the data of each individual patient was 
considered separately. 
Baseline NIRS Saturation varied from 49% to 74% (mean 66.8% S.D 7.9%). This was 
taken as an average of the first 600 seconds of recording (after setup and the 
confirmation of a stable reading) on the ipsilateral channel to invasive monitoring. 
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These are similar figures to those recorded in our previous investigations using similar 
equipment in healthy individuals
20
.   
7.5.1 Predicting changes representing severe hypoxia 
Episodes of severe hypoxia were recorded in 9 of the 12 considered patient PbtO2 data 
streams (Table 1). In the majority of patients (7 of 9) the point of care FD NIRS device 
demonstrated a moderate or good discriminatory (predictive) ability. However the 
remaining 2 demonstrated relatively poor performance.   
Patient 
Surgery prior to 
monitoring? (Y/N) 
AUROC 
Discriminatory performance  
(severe hypoxia) 
3 Y 0.68 Relatively poor 
5 N 0.7 Moderate 
6 N 0.81 Moderate to Good 
7 Y 0.71 Moderate  
9 N 0.88 Moderate to Good 
10 N 0.841 Moderate to Good 
11 Y 0.74 Moderate 
12 N 0.748 Moderate 
14 N 0.685 Relatively poor 
 
Table 7.1. Summary - Severe Hypoxia 
The probabilities (predicted) of severe hypoxia based on changes from baseline values 
were heterogeneous throughout the group. For example, in the case of patient 4 an 
increase in NIRS Saturation of 1% from 58.2% to 59.2% corresponds to a reduction in 
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the odds of being severely hypoxic of only 5% [Odds Ration (OR) 0.95 (0.94, 0.97)].  
However, an increase in NIRS saturation of 5% from 58 to 63% results in a reduction in 
the odds of being severely hypoxic of 74% [OR 0.26 (0.24, 0.29)]. Or alternatively 
decrease in saturation from 63 to 58% increases the relative likelihood of hypoxia by 
383%. In the case of patient 5 an increase of 1% from 69.2% to 70.2% corresponds to a 
reduction in the odds of being severely hypoxic of 53% [OR 0.47 (0.44, 0.49)], and an 
increase in NIRS saturation of 5% from baseline results in a reduction in the odds of 
being severely hypoxic of 98.7% [OR 0.013 (0.009, 0.018)].  Alternatively, a 5% 
decrease in saturation represents an increase in the relative probability of hypoxia of 
769%.   
7.5.2 Predicting Changes representing moderate hypoxia 
Episodes of moderate hypoxia were recorded in 7 of the 12 considered patient data 
streams (Table 2). In a similar pattern to that observed in the prediction of episodes of 
severe hypoxia the majority (5 out of 7) demonstrated moderate to good abilities in the 
discrimination and prediction of episodes of moderate hypoxia. Again, the remaining 2 
patient data streams demonstrated poor predictive performance with 1 recording an 
AUROC of 0.576.  
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Patient 
Surgery prior to 
monitoring? (Y/N) 
AUROC 
Discriminatory performance  
(moderate hypoxia) 
3 Y 0.731 Moderate 
5 N 0.576 Poor 
6 N 0.68 Moderate  
7 Y 0.774 Moderate  
9 N 0.905 Good 
10 N 0.771 Moderate 
13 N 0.591 Poor 
 
Table 7.2. Summary – Moderate Hypoxia 
The probability of predicting moderate hypoxia throughout the group was varied, and 
non-linear in a similar fashion to that demonstrated in episodes of severe hypoxia. In 
Patient 9 and increase in NIRS saturation of 1% (from 61.4% to 62.4%) corresponds to 
a decrease in the odds of being mildly hypoxic of 40% [OR 0.60 (0.50, 0.72)].  
However, an increase of 5% in NIRS sat % from 61.4% to 66.4% results in a decrease 
in the odds of being mildly hypoxic of 94% [OR 0.06 (0.04, 0.08)]. This represents an 
increase in the relative likelihood of hypoxia following a 5% reduction in saturation of 
approximately 1660%.  
In contrast to this an increase of 1% from 57.2% to 58.2% in patient 4 corresponded to 
an increase in the odds of mildly hypoxia of 0.009% [OR 1.00 (0.99, 1.01)], with an 
increase in NIRS sat % from 57% to 62% resulting in an increase in the odds of being 
mildly hypoxic of 2% [OR 1.02 (0.97, 1.06)]. Conversely, a reduction in saturation of 
5% will increase the relative likelihood of mild hypoxia by approximately 98%.  
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7.6 Discussion 
Currently within the management of TBI invasive intra-cranial monitoring is 
undertaken exclusively within the confines of specialist critical/intensive care units. 
Alongside the avoidance of the significant cost and morbidity associated with an 
invasive intra-cranial monitor, a non-invasive equivalent has the potential to allow the 
brain tissue specific direction of therapy to be undertaken in a much wider range of 
environments
21, 22
.  Studies utilising commercially available NIRS devices similar in 
portability to the system utilised in our investigation have demonstrated that the use of 
this technology is entirely possible in a wide range of pre-hospital envoronments
23, 24
. 
This also has the potential to move brain tissue directed resuscitation measures closer to 
the time of injury.  
For a new monitoring device (or modality) to potentially be utilised independently for 
the process of clinical decision making in any medical discipline it should usually 
demonstrate excellent agreement with an established clinical gold standard (measuring 
parameter/predicting an event / predicting outcome). Intuitively, the proposed novel 
method of measuring a given physiological parameter should detect every clinically 
significant change in parameters that the previous gold standard reports.  
Alternatively if the performance differs, the discrepancy in reports should be justifiable 
by the avoidance of certain inherent limitations or complicating factors (I.e. invasive vs 
non invasive – the risk of missing a significant physiological change is offset by the 
reduction in risk associated with the invasive application). The measurement of cerebral 
haemodynamic activity in resuscitation is by no means isolated in the quest for a non-
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invasive device to demonstrate equivalence to (and displace) an existing expensive or 
invasive clinical gold standard. In cases where non-invasive measurement of blood 
pressure (a conceivably simpler prospect to cerebral vascular activity) in the critically ill 
has been compared to novel non-invasive alternatives, the invasive method of 
monitoring is still recommended as irreplaceable with respects to critical care
25, 26
. 
Within the recent literature, the reported risk of morbidity with conventional invasive 
intra cranial monitoring is approximately 1% and 0.5% for haematoma and infection 
respectively
27, 28
 with intra-parenchymal pressure transducers. This risk has been 
demonstrated as significantly higher when an intra ventricular catheter is utilised
29, 30
.  
These risks must therefore be considered against the possibility of a ‘missed’ critical 
physiological episode that ‘should’ be actively managed. No trial has yet assessed the 
difference in outcome between invasively guided TBI management and NIRS
8-10
, 
therefore quantification of this risk/benefit with currently utilised NIRS technology is 
imprecise.    
The results of this investigation indicate that (in its current state) the point of care FD 
enhance NIRS device tested does not demonstrate sufficient reproducibility in its ability 
to predict changes in PbtO2 to replace the current invasive gold standard. A consistently 
very good predictive power would be required in all cases for this to be plausible, and 
even in our modest number of patients it is demonstrable that the margin of 
disagreement is too great. Within the NIRS parameter recovery apparatus there are a 
number of factors that may account for inconsistency, including site and placement 
technique of probes, ambient noise and movement artefact, together with evolving 
oedematous changes within the extra cranial tissues due to diffuse injury of the upper 
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extremity.  However this was a pragmatic investigation into the use of this technology, 
and a certain degree in the heterogeneity of application of the skin probes, movement 
and ambient artefact together with changes in the skin tissue (including sweating) 
themselves would be inevitable and expected in clinical practice. We therefore maintain 
that these findings are directly translatable to the technology within the intensive 
management of TBI.  
A previous investigation into the abilities of point of care NIRS to predict changes in 
invasively measured brain tissue oxygen concluded that in its current state NIRS is not 
sufficiently sensitive to replace intra cranial measurement. It utilised a continuous wave 
device, and the invasive measurements were made with a Clarke cell based probe
31
. 
Other significant differences exist in the relative methodologies of this study and our 
own; with Leal-Novel et al taking sorter 1 hour observations in a larger number of 
injured patients (22 vs 16), a different definition of sever and moderate hypoxia, and a 
significantly different number of paired measurements (42,000, vs 1,02,1000). Despite 
this the results in both investigations are comparable despite the potential advantages of 
the FD NIRS device utilised in our trial. Specifically Leal-Novel et al observed that the 
NIRS device could detect severe hypoxic changes (defined as a PbtO2 of <12mmHg) 
with an AUROC of 0.82 and moderate hypoxic changes (defined as a PbtO2 of 
15mmHg) with an AUROC of 0.62.  
The FD NIRS device utilised quantifies a global tissue value for light scatter and is not 
able to topographically isolate values for scatted within individual layers of tissue, this 
therefore does not represent a definitive solution to excluding the influence of 
superficial extra cranial tissue or the definitive quantification of chromopheres
32
. This 
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may account for the apparent inability of this device to improve the predictive power 
seen in the previous similar investigation utilising continuous wave technology
31
.  
As the measurement of PbtO2 is local and not absolutely uniform in terms of its 
proximity to the field of NIRS acquisition (although always from the ipsilateral cerebral 
hemisphere) a degree of variability in the measurement could certainly be attributed to 
our invasive gold standard. This potentially represents a limitation in our investigation; 
as the comparison of two largely focal measurements that are not in all cases measuring 
at identical locations is sub-optimal. This is an important factor in drawing conclusions 
from this investigation (and previous similar investigations), as it could certainly 
account for a degree of inconsistency in the agreement between modalities.  
7.7 Conclusions 
A clear predicative relationship between NIRS parameters measured by this point of 
care device utilising FD technology and invasively measured PbtO2. However, 
currently this has not demonstrated to be sufficiently robust for the non invasive 
cerebral oxygenation measurements to replace the existing invasive gold standard in 
clinical practice.  
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CHAPTER 8:  PROJECT CONCLUSIONS  
Near infrared spectroscopy (NIRS) clearly remains one of the best currently available 
prospects for a practical and cost effective non-invasive monitoring modality in 
Traumatic Brain Injury (TBI).  
This investigation has demonstrated a number of key abilities of point of care NIRS 
technology, quantifying clearly translatable strengths and addressing certain existing 
concerns regarding the abilities of this method of measuring cerebral oxygenation.  
However, despite its obvious and continually improving abilities there is still 
development required in a number of aspects of NIRS to allow it to progress to 
eventually be incorporated as a mainstream independent method of monitoring cerebral 
physiology within TBI care. 
At the beginning of this series of observations a number of specific research questions 
were set out; we shall discuss these individually.   
1. To assess the current body of evidence relating to the abilities of NIRS (in all forms) 
to be utilised as an independent monitoring modality in the context of TBI.   
The literature review undertaken at the beginning of this investigation specified a 
number of established abilities and disabilities of NIRS technology within the 
specific arena of adult TBI. The reported evidence based abilities included the 
ability to detect the evolution of new focal mass lesions (haematomas), and evolving 
cerebral oedema.  However there is currently not sufficient evidence to suggest this 
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modality can be a substitute for CT imaging or invasive intra-parenchymal 
measurements.  
The review also highlighted a number of technological advances made in recent year 
that intend to address a number of these potential shortcomings. As these techniques 
are introduced and trialled within the clinical TBI setting the potential applications 
for NIRS based monitoring within this context could significantly increase.  
2. To ascertain if a clinically viable NIRS device utilising frequency domain 
technology offers any clear translatable advantages to TBI care over previously 
utilised technology in detecting clinically important changes in cerebral physiology.  
Our investigation to assess the potential advantages of a NIRS device utilising 
frequency domain (FD) parameter recovery technology over a continuous wave 
(CW) based device (widely utilised in the clinical literature) employed a model of 
controlled step-wise hypoxia to contemporaneously test our 2 selected devices. We 
concluded that no apparent advantage was demonstrable by the FD NIRS device in 
its tested state. There were however a number of key limitations to this assessment. 
Although superficially this appears to be a test of two NIRS devices, with one 
benefiting from an enhanced parameter recovery method there are practically a 
number of confounders. Firstly both devices utilised very different parameter 
reconstruction algorithms, which would contribute significantly to the nature of 
observation reported by each system. In addition to this the optode (source/detector) 
layout for each device differed which would have a measurable effect on depth 
sensitivity. Of note also are the wavelengths of light utilised and the different way in 
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which each monitor delivers and retrieves light from the target tissue (the FD device 
utilising fibre optic bundles, prisms and photo-multiplication and the CW device 
applying diodes directly to the tissue surface).  
Despite these limitations a certain number of pragmatic conclusions can be drawn. 
The FD device has no overt intuitive disadvantages, but does theoretically benefit 
from the enhanced parameter recovery technique. Whatever benefits this provides, 
when incorporated into a bedside system do not seem to provide any advantage in 
detecting frank and significant changes in cerebral oxygenation over a comparable 
CW system. Therefore this may imply that for the detection of significant shifts in 
physiology such as those experienced in severe hypoxia the potential benefits of FD 
are superfluous. However this investigation cannot be conclusive in this respect.          
3. To ascertain if the effect of confounding superficial (extra cranial) vascular activity 
prevents the effective identification of significant physiological changes pertinent to 
TBI care by NIRS devices utilising frequency domain parameter recovery.  
In this experiment to significantly modify the quantity of blood within the 
superficial extra-cranial tissue a solution of local anaesthetic and epinephrine was 
infiltrated into the tissues directly situated underneath the NIRS optodes. The 
reduction in the blood flow and tissue reactivity to systemic blood pressure changes 
was confirmed by cutaneous laser Doppler and was consistent with previous reports 
in the surgical literature as referenced.  
The Valsalva manoeuvre (VM) was utilised as a clinically relevant model, 
translatable to TBI due to the reduction in cerebral perfusion pressure seen. 
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Potentially due to the enclosed nature of the brain within the scull, and the 
significantly higher basal metabolic demands of the cerebral tissue we observed a 
significantly different pattern of activity during VM between the extra cranial and 
cerebral tissues. Critically the morphology of the response in terms of absolute 
changes during VM did not change significantly with the addition of the 
epinephrine. 
A key limitation of this investigation is the extra-cranial tissue responses were not 
taken from the same site as those of the brain directed observations. This was due to 
equipment limitations, in that the probes and parameter retrieval on this device were 
configured for deep retrieval and therefor in order to obtain non-brain activity from 
an equivalent depth we needed to locate the probes over the zygomatic arch. This 
incorporated skin, bone fat and muscle tissue only (with the absence of sinus air 
chambers). It also permitted contemporaneous measurements of intra and extra-
cranial tissues during VM with the existing equipment.  
Despite this a potentially key observation can be made and by this experiment; that 
the influence of the superficial tissue on the output parameters of this NIRS device 
are not sufficient in magnitude to modify the morphology of response to the 
significant shifts in physiology seen secondary to VM. This is demonstrated by both 
the different responses seen by the separate tissues, and the absence of significant 
change in the response to changing the perfusion of the tissue (epinephrine).  
The translatable deduction from this is that the significant changes and variety of 
skin and superficial tissue perfusion seen in traumatic injury (haemorrhagic shock) 
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may not significantly impact NIRS output parameters retrieved from cerebrally 
targeted optodes.       
4. To compare the abilities of a clinically viable NIRS device utilising an advanced 
recovery technique (frequency domain) to established gold standard measured of 
cerebral physiology (functional magnetic resonance imaging). 
Utilising similar modelling methods to those in the previously documented 
experiments we intended to assess if a point of care FD NIRS device has similar 
abilities to functional magnetic resonance imaging (fMRI) in tracking clinically 
relevant changes in cerebral physiology. 
We demonstrated that this device has similar abilities to fMRI in differentiating 
between superficial extra-cranial and brain tissue during VM, in that a similar 
physiological pattern of activity was observed in both when directed at these 
respective tissues. This also served to reaffirm the observations made in the previous 
investigation utilising the VM. We also observed comparable abilities between this 
simply applied (2 channel) NIRS device and fMRI in tracking physiological changes 
over time due to hyperventilation.  
The important contribution of this particular investigation was to confirm the 
abilities of this NIRS device benefiting from FD technology (although not 
specifically testing this aspect) to track clinically relevant (significant shifts) in 
intra-cranial physiology as well as the (currently accepted) available gold standard. 
It also strengthened the argument that these changes are seen predominantly from 
the brain tissue and independent or activity within the extra-cranial compartment 
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(within the context of these clinically relevant significant shifts in oxygenation and 
perfusion).    The results also supported our predictions regarding the Valsalva as a 
potential tool to initiate a pattern of response in which intra and extra-cranial tissue 
can be clearly differentiated.  
5. To investigate if a clinically viable NIRS device utilising frequency domain 
technology has the ability to detect changes in invasively measured brain tissue 
oxygen tension in patients who have sustained severe traumatic brain injury. From 
this I would like to ascertain if this non-invasive technology is currently able to 
replace this current invasive gold standard.   
The central question of this experiment was to assess if a point of care NIRS device 
benefiting from FD parameter recovery technology could demonstrate equivalence 
and the ability to replace the clinical gold standard of invasive brain tissue oxygen 
tension measurement (PbtO2). As discussed in the original literature review, 
previous studies published concluded that CW NIRS devices did not demonstrate 
sufficient accuracy and consistency in detecting PbtO2 to replace this modality in 
clinical TBI management. This investigation intended to ascertain if the utility of the 
enhanced FD parameter recovery technique improved the performance of NIRS 
technology in this role.    
Our investigation did not demonstrate any observable improvement in performance 
in the FD device. However the methodology employed was discernable different 
from previous investigations, with a shift in focus away from short period 
observations (1 hour or less) to continuous monitoring over many hours. Although 
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our study included fewer patient subjects, in included a far greater number of data 
point comparisons. The way in which these differences in methodology would 
influence the outcome observed is unclear, however it is our opinion that longer 
continuous observation provides a more accurate reflection of how the technology 
would be pragmatically utilised.  
It is important to reiterate that PbtO2 is a local measurement, and in any such 
investigation the tissue in which NIRS parameters are recovered from is frequency 
going to be anatomically discreet to that in which PbtO2 are measured. This 
combined to a number of  other limitations highlighted in this work imply that 
failure for these measurements to accurately reflect one another may not simply be 
attributable to limitations in the NIRS technology.  
8.1 What has this work added to the current body of evidence? 
This collection of investigations has potentially expanded the existing knowledgebase 
as to the ability of NIRS based technology to be utilised within the context of TBI care. 
Specifically it has clarified the abilities and limitations of selected FD enhanced 
clinically available technology (within a relevant context) to allow better-informed 
application of the monitor.   
It is conceivable that to truly assess the abilities of NIRS based technology within TBI 
care, data relating directly to patient outcome is required. This will be very much taken 
forward into the future work of our collaborators. A great many investigations 
(including our own) seek to ascertain the ability of this modality to replace or reflect 
current mainstream monitoring technology, highlighting practical and cost advantages 
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as justification for the comparison. It is however completely conceivable that eventually 
the direction of therapy to independently optimise NIRS based parameters could 
contribute to an improved outcome in TBI patients (independent of any co-optimisation 
of other measured parameters). It is important to consider that NIRS technology is 
measuring a different (however related/similar) phenomena to the previously discussed 
gold standard(s) and other mainstream monitoring devices within TBI care (intra cranial 
pressure). Therefore, it is totally intuitive that there will never be a perfect agreement 
between measurements.  
From these concepts further work can be planned, utilising NIRS technology with a 
range of novel enhancements as not only a substitute for more invasive, expensive or 
impractical modalities; but as its own parameter reflecting the specific physiology that it 
has been developed to observe.  
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